Effect of functional feeds on fatty acid and eicosanoid metabolism in liver and head kidney of Atlantic salmon (Salmo salar L.) with experimentally induced Heart and Skeletal Muscle Inflammation by Martinez-Rubio, Laura et al.
Martinez-Rubio L, Morais S, Evensen O, Wadsworth S, Vecino 
JLG, Ruohonen K, Bell JG & Tocher DR (2013) Effect of 
functional feeds on fatty acid and eicosanoid metabolism in 
liver and head kidney of Atlantic salmon (Salmo salar L.) with 
experimentally induced Heart and Skeletal Muscle 























NOTICE: this is the author’s version of a work that was accepted for publication in Fish and Shellfish 
Immunology. Changes resulting from the publishing process, such as peer review, editing, corrections, 
structural formatting, and other quality control mechanisms may not be reflected in this document. Changes 
may have been made to this work since it was submitted for publication. A definitive version was subsequently 
published in Fish and Shellfish Immunology, [VOL 34, ISS 6 (2013)] DOI:  
http://dx.doi.org/10.1016/j.fsi.2013.03.363   
 1 
Effect of functional feeds on fatty acid and eicosanoid metabolism in liver 1 
and head kidney of Atlantic salmon (Salmo salar L.) with experimentally 2 
induced Heart and Skeletal Muscle Inflammation 3 
 4 
Laura Martinez-Rubio1*, Sofia Morais1, Øystein Evensen2, Simon Wadsworth3, Jose G. 5 
Vecino3, Kari Ruohonen3, J. Gordon Bell1, Douglas R. Tocher1 6 
 
7 
1Institute of Aquaculture, School of Natural Sciences, University of Stirling, Stirling FK9 4LA, 8 
Scotland, UK, 2Norwegian School of Veterinary Science, PO Box 8146 Dep, N-0033 Oslo, Norway, 9 




*E-mail: laura.martinez@stir.ac.uk 14 
15 
FSIM-D-12-00527 Revision2.docx
Click here to view linked References
 2 
Abstract 16 
Heart and Skeletal Muscle Inflammation (HSMI) is an emerging viral disease caused by a novel 17 
Atlantic salmon reovirus (ASRV) affecting farmed fish. Primary symptoms associated with HSMI 18 
include myocardial and skeletal muscle necrosis indicating a severe inflammatory process. Recently, 19 
we applied the concept of clinical nutrition to moderate the long-term inflammatory process associated 20 
with HSMI in salmon subjected to experimental ASRV challenge. The use of functional feeds with 21 
lower lipid (hence energy) content reduced the inflammatory response to ASRV infection and the 22 
severity of associated heart lesions. The aim of the present study was to elucidate possible mechanisms 23 
underpinning the observed effects of the functional feeds, focussing on eicosanoid and fatty acid 24 
metabolism in liver and head kidney. Here we show that liver was also a site for histopathological 25 
lesions in HSMI showing steatosis reflecting impaired lipid metabolism. This study is also the first to 26 
evaluate the expression of a suite of key genes involved in pathways relating diet and membrane 27 
phospholipid fatty acid compositions, and the inflammatory response after ASRV infection. The 28 
expression of hepatic Δ6   and  Δ5  desaturases was higher in fish fed the functional feeds, potentially 29 
increasing their capacity for endogenous production and availability of anti-inflammatory EPA. Effects 30 
on mobilization of lipids and changes in the LC-PUFA composition of membrane phospholipids, along 31 
with significant changes in the expression of the genes related to eicosanoid pathways, showed the 32 
important role of the head kidney in inflammatory diseases caused by viral infections. The results from 33 
the present study suggest that clinical nutrition through functional feeding could be an effective 34 
complementary therapy for emerging salmon viral diseases associated with long-term inflammation. 35 




      Heart and Skeletal Muscle Inflammation (HSMI) is an emerging viral disease caused by a novel 39 
Atlantic salmon reovirus (ASRV) [1] particularly affecting farmed salmon in Norway [2]. Mortality 40 
varies between outbreaks from 0 to 20%, and the morbidity of the lesions can reach 100%, affecting 41 
almost all fish in a farm, leading to significant growth reduction and financial impact [3]. The main 42 
symptoms associated with HSMI are epi-, endo- and myocarditis, and myocardial and red skeletal 43 
muscle necrosis, indicating that these tissues experience a severe inflammatory process. Early stages of 44 
the disease have been reported around five months after transfer to sea water and the cardiac lesions 45 
persist for several months until the fish are able to control the infection and reduce tissue damage [4]. 46 
Thus, factors modulating and dampening the inflammatory process might be key to mitigating the 47 
clinical symptoms and improving performance, including growth, of affected fish. 48 
         Polyunsaturated fatty acids (PUFA), in particular long-chain PUFA (LC-PUFA), have essential 49 
roles in the development and control of inflammatory responses. They are important components of 50 
plasma membranes that are integral in controlling membrane-signalling pathways. A key link between 51 
fatty acid composition of immune cell membranes and the inflammatory process are eicosanoids, lipid 52 
mediators including prostaglandins (PG), leukotrienes (LTB) and thromboxanes (TX) that modulate the 53 
intensity and duration of inflammatory responses in humans [5] and fish [6]. In mammals, arachidonic 54 
acid (ARA, 20:4n-6) is the major LC-PUFA precursor of eicosanoids including leukotriene B4 (LTB4) 55 
and prostaglandin E2 (PGE2), which are two of the main eicosanoids in relation to immune-related 56 
pathways [7,8]. LTB4 is an important chemotactic agent for leukocytes, enhancing the proliferation of 57 
T and B cells, increasing the production of tumour necrosis factor  (TNFα) and interleukins, IL-1 and 58 
IL-6, and inducing NK cell activity, thus being highly relevant in viral infections [9]. PGE2 is generally 59 
related with pro-inflammatory and immunosuppressive functions, although it has also been associated 60 
with anti-inflammatory actions during resolution of the inflammatory process [10]. In contrast, the n-3 61 
LC-PUFA, eicosapentaenoic acid (EPA, 20:5n-3) and docosahexaenoic acid (DHA, 22:6n-3), are 62 
considered anti-inflammatory fatty acids, with EPA being particularly relevant as an antagonist of 63 
ARA, acting as a competitive substrate for the main enzymes of the eicosanoid synthesis pathways, 64 
cyclooxygenase (COX) and lipoxygenase (LOX), giving rise to anti-inflammatory eicosanoids and 65 
inflammation-resolving E-series resolvins [10,11]. Although fish cell membranes have higher levels of 66 
EPA than ARA, previous studies indicated that ARA was the preferred substrate for the enzymes 67 
involved in eicosanoid pathways in fish, as in mammals [12]. Similarly, altering the ratio of ARA and 68 
EPA in cell membranes alters the production of eicosanoids and modulates the inflammatory response 69 
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in fish as it does in mammals [13]. Vegetable oils (VO) are generally rich in n-6 PUFA and do not 70 
contain n-3 LC-PUFA, however, the replacement of dietary fish oil (FO) by VO does not appear to 71 
negatively affect growth performance in salmonids [14]. Therefore VO have been used in the past few 72 
years as a sustainable alternative to dietary FO in fish farming. However, the fatty profiles of the 73 
alternative feeds, especially the reduction in n-3 LC-PUFA levels and the n-3/n-6 PUFA ratio, are 74 
directly reflected in fish tissue fatty acid compositions. This is becoming of increasing interest in 75 
relation to potential modulation of immune and inflammatory response pathways [15-17].  76 
    In this context, we recently applied the concept of clinical nutrition to moderate the long-term 77 
inflammatory process associated with HSMI in salmon [18]. In this study we investigated the effects of 78 
functional feed formulations, in comparison to a standard commercial feed, on inflammatory responses 79 
in the heart of Atlantic salmon subjected to experimental ASRV challenge. The standard reference diet 80 
(ST diet) contained 31% lipid and a digestible energy content of 22 MJ/Kg while the functional feeds 81 
had reduced DE levels (18 MJ/Kg) achieved through lower lipid contents (18%), increased levels of 82 
EPA, and increased n-3/n-6 PUFA and EPA/ARA ratios (FF1 and FF2 diets). A milder (dampened) 83 
inflammatory response to ASRV infection, and reduced severity of heart lesions was found in fish fed 84 
the functional feeds, particularly FF1, and transcriptome (microarray) analysis of heart showed that 85 
expression of inflammation/immune related genes was greatly affected by the functional feeds. This 86 
study demonstrated that dietary modulation through clinical nutrition had major influences on the 87 
development and severity of the response to ASRV infection in salmon, and the modulation of gene 88 
expression between fish fed the different feeds provided insight into the molecular mechanisms of 89 
progression of the inflammatory and immune responses to ASRV infection in salmon. However, the 90 
study did not enable the identification of the precise physiological and molecular mechanisms by which 91 
the functional feeds provided enhanced immuno-inflammatory protection.  92 
        The primary objective of the present study was to elucidate possible mechanisms underpinning the 93 
observed effects of the functional feeds. Given that the main differences between the standard and 94 
functional feeds were in their lipid fractions, this study focussed on lipid metabolism, membrane fatty 95 
acid composition, and fatty acid metabolic pathways involved in LC-PUFA biochemistry and 96 
inflammatory processes, which would be affected by changes in dietary fatty acid composition. Thus, 97 
head kidney, heart and liver from the same fish sampled in the previous study were analysed and fatty 98 
acid compositions of the cell membrane phospholipids were determined. In addition, liver 99 
inflammation was measured, given that it is one of the tissues affected in HSMI, and the expression of 100 
genes, including transcription factors controlling aspects of lipid metabolism, and those involved in 101 
LC-PUFA biosynthesis and eicosanoid metabolism, was determined in liver and head kidney. 102 
 5 
Material and methods 103 
 104 
Fish and feeds 105 
     Three fishmeal-based diets were formulated and manufactured by EWOS Innovation (Dirdal, 106 
Norway).  Formulation and proximate composition of the feeds are indicated in Tables 1 and 2, details 107 
as previously reported [18]. A total of 450 Atlantic salmon (Salmo salar L.), AquaGen strain, were 108 
distributed into nine tanks (50 fish/tank)  at the EWOS facility, Lønningdal, Norway and fed one of the 109 
experimental feeds in triplicate tanks for a period of 8 weeks prior to being transferred to the challenge 110 
facility. All fish were weighed at the start and end of the feeding phase and doubled their weight in the 111 
8-week period. Initial weights (g) were 109 ± 18, 109 ± 19 and 111 ±17, respectively, and final weights 112 
were 199 ± 40, 220 ± 42 and 219 ± 37, respectively, for fish fed the ST, FF1 and FF2 diets (means ± 113 
SD, n = 150). There were no significant differences in initial weights or in final weights between fish 114 
fed any of the treatments.  115 
ASRV Challenge 116 
        After the pre-feeding period, the fish (non-vaccinated) were transferred to the challenge facility at 117 
the Industrial and Aquatic Laboratory (ILAB), Bergen, Norway. A total of 390 fish (130 fish per 118 
treatment), initial average weight 220g (±3.2g, standard error), were distributed into two independent 119 
experimental rooms each containing 9 flow-through tanks (3 tanks per dietary treatment in each 120 
system). Filtered seawater (approximately 30‰) with a constant temperature of 10 ± 1°C was supplied 121 
with a flow sufficient to maintain oxygen concentration in the outlet water at   8 mg/L (48 L / kg fish / 122 
h). The light regime was set at 12h:12h light/dark. The fish were acclimated for 2 weeks prior to 123 
challenge. Fish were fed the same diets during the acclimation period, pre-challenge (8 weeks) and 124 
post-challenge periods (16 weeks) No previous diseases were described. The fish were sedated using 125 
Aqui-S (at final concentration of 5 mg/L of isoeugenol) followed by anaesthesia in benzocaine 126 
(Benzoak) using a final concentration of 30 ml/L of water. After an initial sampling of 10 fish per 127 
dietary treatment, a total of 360 fish (20 per tank; 60 fish per diet per treatment room) were challenged 128 
by intramuscular injection (0.1 ml on each side close to the lateral line) of inoculum collected from cell 129 
culture supernatant of ASRV as described in detail previously [18]. 130 
Sampling 131 
Ten fish from each dietary treatment group (5 fish from each of the two independent systems) were 132 
sampled randomly at 8- and 16-weeks post-challenge. Fish were anaesthetized as above, killed by a 133 
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blow to the head, and heart, liver and head kidney were collected. A part of each liver sample was 134 
transferred to 10% buffered formalin for histological analyses and another part was immediately frozen 135 
in liquid N2 and stored at -80 oC prior to lipid and molecular analyses. Heart and head kidney were also 136 
immediately frozen in liquid N2 and stored at -80 oC. 137 
Liver histology 138 
Liver histology was assessed for micro- and macrovesicular steatosis by light microscopy of 139 
hematoxylin and eosin-stained sections. At least five different fields at 20x original magnification 140 
where examined and scored for presence of formation of vesicles of individual hepatocytes. A 141 
subjective assessment of the proportion of hepatocytes that showed these changes was also made. Liver 142 
steatosis scores were ranked according to a non-continuous score grade from 0 to 5 (Table 3). All 143 
sections were scored double-blinded. A selected proportion of liver samples (n = 15) were stained with 144 
Periodic-Acid Schiff stain (PAS) according to standard methods with the purpose to rule out vacuole 145 
formation as a cause of glycogen storage. Positive samples were included and also treated pre-treated 146 
with diastase/amylase [19]. 147 
      All data preparation and simulation output analysis was conducted using the R language [20]. The 148 
model was a mixed-effects linear model estimated with the lmer function in the lme4 package. The 149 
treatment estimates were based on posterior simulation (n=2500) with 95% credible intervals as 150 
absolute and proportional to the reference level (control diet). Histopathological scores were analysed 151 
by using a multilevel ordered categorical logistic regression because the data are multinomial. The 152 
model was written in BUGS language [21] and fitted with JAGS [22]. Vague non-informative uniform 153 
priors (0,100) were given for the variance parameters and vague non-informative normal priors N (0, 154 
1.0E  +  4)   for   all   other   parameters.   25000   “burn-in" simulation runs were used to adapt the Markov 155 
Chain Monte Carlo (MCMC) before subsequent 2500 runs that were used for inference. Three chains 156 
were run in parallel, i.e. there were a total of 7500 simulations for inference. These were thinned so that 157 
only every 10th simulation was saved to reduce the size of saved objects and to reduce the effects of 158 
autocorrelation. In effect, the posterior density is based on 750 draws from the posterior probability 159 
distribution. Convergence of the MCMC simulation was judged by the Gelman-Rubin convergence 160 
diagnostic. 161 
Lipid analyses 162 
Total lipid from approximately 1g of liver, 0.5 g of head kidney and 0.2g of heart was extracted by 163 
homogenization in chloroform/methanol (2:1, by volume) according to Folch et al. [23], and 164 
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determined gravimetrically. Total lipid from head kidney and heart samples was separated by one-165 
dimensional thin-layer chromatography (TLC) and the major phospholipid classes, phosphatidylcholine 166 
(PC) and phosphatidylethanolamine (PE), were isolated as described previously [24]. Fatty acid methyl 167 
esters (FAME) of heart and head kidney phospholipid classes and liver total lipid were prepared by 168 
acid-catalyzed transmethylation [25]. FAME were separated and quantified by gas chromatography 169 
[26]. Tissue and diet lipid class compositions were determined by single-dimension double-170 
development high-performance thin-layer chromatography (HPTLC) and densitometry [27]. 171 
Significance of differences due to diet and time were determined by two-way ANOVA (p<0.05) using 172 
the SPSS 19.0 statistical package (SPSS Inc., Chicago IL, USA) of arcsin-transformed data. 173 
Real-time quantitative PCR  174 
Expression of 13 selected genes was studied by reverse transcription real time quantitative PCR 175 
(qPCR). Six genes are related to the eicosanoid biosynthesis pathway, secretory phospholipase A2 or 176 
sPLA2 (PLA2G1), cytosolic calcium-dependent phospholipase A2 or cPLA2 (PLA2G4), cytosolic 177 
calcium-independent phospholipase A2 or iPLA2 (PLA2G6), cyclooxygenase 2 (COX2), 5-178 
lipoxygenase-activating protein (FLAP) and arachidonate 5-lipoxygenase (ALOX5). Four genes are 179 
involved in LC-PUFA biosynthesis, Δ5 and Δ6 fatty acyl desaturases (D5FAD, D6FAD) and 180 
elongases 5 and 2 (ELOVL5, ELOVL2). The remaining genes are transcription factors involved in the 181 
regulation of storage and catabolism of dietary fats, and recently associated with the immune response, 182 
peroxisome proliferator-activated receptors α, β and γ (PPAR-A, PPAR-B and PPAR-G). The 183 
primer sequences were obtained either by literature searches or designed from EST sequences 184 
corresponding to candidate genes of interest using the Primer3 software 185 
(http://biotools.umassmed.edu/bioapps/primer3_www.cgi) (Table 4). In addition, amplification of two 186 
reference genes, cofilin-2 and elongation factor-1α  (elf-1α) was performed as they had been identified 187 
in previous salmon qPCR studies as suitable reference genes on the basis of constant expression 188 
between different feeds and time points [18,28], and their expression was equally stable under the 189 
present study’s  conditions.  190 
Details of the qPCR protocol have been reported previously [18]. Briefly, 2 µg of column-purified 191 
total RNA per sample was reverse transcribed into cDNA using the High-Capacity cDNA RT kit 192 
(Applied Biosystems,  Paisley,  U.K.),  following  manufacturer’s  instructions,  using  a  mixture  of  random  193 
primers (1.5µl as supplied) and anchored oligo-dT (0.5 µl at 400 ng/ µl, Eurofins MWG Operon, 194 
Ebersberg, Germany). qPCR amplifications were carried out in duplicate (Quantica, Techne, 195 
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Cambridge, U.K.) in a final volume of 20 µL containing either 5 µL (most genes) or 2 µL (reference 196 
genes and other highly expressed genes) diluted (1/20) cDNA, 0.5 µM of each primer and 10 µL 197 
AbsoluteTM QPCR SYBR® Green mix (ABgene). Results were analysed using the relative expression 198 
software tool (REST 2009, http://www.gene-quantification.info/), which employs a pair-wise fixed 199 
reallocation randomisation test (10,000 randomisations) with efficiency correction to determine the 200 
statistical significance of expression ratios (or gene expression fold-changes) between two treatments 201 
[29]. Additionally, sequencing of amplicons corresponding to new primer designs enabled the 202 




Liver histology  207 
The liver histology scores, based on the degree of steatosis was read as vacuole-formation in 208 
hepatocyte cytoplasm characterised by both micro- and macro-vesicular lesions (Fig.1). There were 209 
clear differences between fish fed the functional feeds and fish fed the ST diet at 8-weeks post-210 
challenge, with the latter group presenting higher micro- and macro-vesicular steatosis. Quantification 211 
of the liver histopathology thus showed that both the incidence (percentage of fish sampled) and 212 
severity (based on the scoring system in Table 3) of steatosis at 8-weeks post challenge was clearly 213 
greater in salmon fed the ST diet compared to fish fed the two functional feeds (Fig. 2). At 16 weeks 214 
post-challenge, there were no longer differences in liver histology between the three dietary treatments. 215 
Lipid content and composition of tissues  216 
The total lipid and triacylglycerol (TAG) contents of liver were lower in fish fed the functional feeds 217 
compared to fish fed the ST diet with higher lipid (Table 5). In contrast, diet had no effect on the total 218 
lipid or TAG contents of heart and head kidney. Total lipid levels in all three tissues decreased during 219 
the time course of the infection irrespective of diet, but a significant interaction between diet and time 220 
was observed for lipid class compositions, given that these showed a change over time that was 221 
variable and dependent on diet.  In liver, this decrease was greatest in fish fed diet ST, which also 222 
showed a large decline in TAG. The decline in tissue lipid content over the course of the infection was 223 
greatest in head kidney. This was associated with decreased percentages of TAG in fish fed the 224 
functional feeds and, conversely, with reduced proportions of polar lipids in fish fed diet ST (Table 5). 225 
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In heart, the results were less clear and the lower lipid content at 16-weeks post-challenge was 226 
associated with lower proportions of polar lipids in fish fed diet ST but lower TAG in fish fed FF2. 227 
Fatty acid compositions of tissues 228 
The fatty acid compositions of the functional feeds were characterised by increased proportions of 229 
saturated and n-3 PUFA, decreased proportions of monoenes and n-6 PUFA, and increased n-3/n-6 230 
PUFA and EPA/ARA ratios (Table 1). The differences in saturated and monounsaturated fatty acid 231 
levels were greatest between diets ST and FF1, whereas the differences in PUFA levels were greatest 232 
between diets ST and FF2. The two functional feeds also varied in the relative proportions of ARA, 233 
EPA and DHA. The fatty acid profile of total lipid of liver generally reflected the composition of the 234 
diets, and therefore showed the same differences between the ST diet and functional feeds, and 235 
between the two functional feeds (Table 6). The overall liver profile changed relatively little during the 236 
course of the infection, especially in the groups of fish eating both functional diets. However, fish fed 237 
the ST diet showed increased proportions of DHA and n-3 PUFA, and decreased proportions of 238 
monoenes at 16 weeks. 239 
      The focus in head kidney was on eicosanoid metabolism, and thus fatty acid compositions were 240 
determined in the sources of precursor LC-PUFA, the membrane phospholipid classes 241 
phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylinositol (PI) and 242 
phosphatidylserine (PS). The fatty acid profiles of the major phospholipids (PC and PE) in head kidney 243 
generally showed some significant effects of diet, including increased proportions of saturated fatty 244 
acids and decreased proportions of n-6 PUFA in fish fed the functional feeds, but the differences were 245 
not as pronounced as in total lipids of liver (Table 7). Irrespective of diet, the proportions of the 246 
eicosanoid precursors, ARA and EPA and the EPA/ARA ratio, declined in all head kidney 247 
phospholipids, except PI, over the course of the infection, being significantly reduced in fish at 16-248 
weeks compared to 8-weeks post-challenge (Tables 7 and 8). The percentage of DHA in PE, PC and PS 249 
was similar in all dietary groups and decreased in PC, but generally not PE or PS, over the time-course 250 
of the infection. In contrast, the percentage of DHA in PI was higher in fish fed the ST diet at 8 weeks 251 
compared to the level in fish fed the functional feeds, and the level in fish fed all of the diets at 16 252 
weeks post-infection (Table 8). 253 
    As with head kidney, the fatty acid composition of the main phospholipid classes of heart also 254 
showed effects of diet over the course of the infection, but they were not very pronounced and occurred 255 
mainly in PC (Table 9). The changes in the proportions of the eicosanoid precursors LC-PUFA showed 256 
a different pattern in heart compared to head kidney. Whereas the proportions of ARA decreased in PC, 257 
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they increased in PE, during the course of the infection. However, within an individual feed, these 258 
changes were minimal. In contrast, changes in EPA were more pronounced, declining in both PC and 259 
PE of heart over the course of the infection. Additionally, it was noteworthy that the decline was much 260 
lower in fish fed the functional feeds (Table 9). As a result, although the EPA/ARA ratio in heart 261 
phospholipids decreased over the course of the infection in all treatments, this was much less 262 
pronounced in fish fed the functional feeds. In contrast the n-3/n-6 PUFA ratio did not change over the 263 
course of the infection. Unfortunately, the small amount of tissue available and the low level of PI and 264 
PS precluded the determination of fatty acid compositions of these phospholipid classes in heart. 265 
 266 
Expression of genes of LC- PUFA biosynthesis pathway in liver 267 
 268 
      The expression of both 6 and 5 fatty acyl desaturases in liver was significantly up-regulated at 269 
both 8- and 16-weeks post-challenge in fish fed the functional feeds compared to fish fed the ST diet 270 
(Fig. 3). There was no difference in expression of these genes between fish fed diets FF1 and FF2, or 271 
between 8- and 16-weeks. In contrast, diet had no significant effects on the expression of fatty acyl 272 
elongases in the liver other than ELOVL5 expression was higher in fish fed diet FF1 compared to fish 273 
fed diet FF2 at 8-weeks post-challenge (Fig. 3). There appeared to be a trend for elongase expression to 274 
be lower at 16-weeks compared to 8-weeks post-challenge, but this was only significant for ELOVL5 275 
in fish fed diet FF1. 276 
Expression of PPARs 277 
     There were no significant effects of diet on the expression of PPARs in liver (Fig. 4). There was a 278 
trend for the expression of all PPAR subtypes to be lower at 16-weeks compared to 8-weeks post-279 
infection in fish fed the ST diet, but this was not statistically significant. Similarly, the expression of 280 
PPAR was lower at 16-weeks compared to 8-weeks post-challenge in all fish, although it was only 281 
significant in fish fed FF1 (Fig. 4). The expression of PPARs in head kidney was also investigated due 282 
to the considerable decrease in lipid content observed in this tissue during the course of the infection, 283 
and the recently reported potential immune modulatory role of these transcription factors (Varga et al. 284 
2011). All three PPAR subtypes showed higher expression at 8-weeks compared to 16-weeks post-285 
challenge, with this being significant in fish fed the functional feeds (Fig. 5). The only significant effect 286 
of  diet  was  increased  expression  of  PPARβ  in  fish  fed  the  ST  diet  compared  to  fish  fed  diet  FF2  at16-287 
weeks post-challenge. 288 
 289 
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Expression of genes related to eicosanoid biosynthesis 290 
 291 
 In head kidney, the expression of three phospholipases reported to be involved in the release of 292 
bioactive fatty acids from cell membranes [8] was higher at 8-weeks compared to 16-weeks post-293 
challenge in fish fed all diets, significantly so in fish fed the functional feeds (Fig. 6). At 8-weeks, the 294 
expression of sPLA2 (PLA2G1) was higher in fish fed the functional feeds compared to fish fed the ST 295 
diet, albeit only significant in fish fed diet FF2. The expression of COX2 (prostaglandin synthesis), 296 
ALOX5 and FLAP, both involved in the biosynthesis of LTs, showed generally few differences 297 
between dietary treatments or over the course of the infection.  However, the expression of ALOX5 298 
was lower in fish fed diet FF1 compared to fish fed diet FF2 at 8 weeks, and expression of COX2 was 299 
significantly higher at 16-weeks compared to 8-weeks post-challenge in fish fed diet FF1 (Fig. 6).  300 
      In heart, phospholipases showed a different pattern of expression compared to head kidney (Fig. 7). 301 
Expression of sPLA2 (PLA2G1) was negligible in heart and therefore no qPCR data are shown for this 302 
tissue. There were no major differences in expression of phospholipases over the course of the 303 
infection, other than higher expression of cPLA2 (PLA2G4) at 8- compared to 16-weeks post-challenge 304 
in fish fed diet FF2. Expression of cPLA2 at 16-weeks and iPLA2 (PLA2G6) at 8-weeks was 305 
significantly lower in fish fed diet FF2 compared to fish fed the other diets. Expression of ALOX5 and 306 
FLAP did not differ between the three dietary groups, but there was a trend for FLAP expression to be 307 
higher at 16- compared to 8-weeks post-challenge, although this was only significant in fish fed diet 308 
FF2 (Fig. 7). In general, the expression pattern of COX2 in heart was similar to that observed in head 309 
kidney, with the expression being significantly lower at 8-weeks post-challenge in fish fed the FF1 diet 310 
compared to fish fed the other diets, and with a general up-regulation of this gene in all dietary groups, 311 
significant in diet FF1, at 16- compared to 8-weeks post-challenge (Fig. 7). 312 
Discussion 313 
 314 
As previously described, reduced dietary lipid along with increased dietary EPA and EPA/ARA ratio 315 
can modulate the inflammatory response and consequently reduce the severity of heart lesions caused 316 
by ASRV infection [18]. The present study investigated the metabolic pathways that link fatty acids, 317 
especially LC-PUFA, with the inflammatory response, correlating the previous findings on dietary 318 
immuno-modulation during ASRV infection, with availability of LC-PUFA and potential effects on 319 
eicosanoid metabolism in the main organs involved in both immune and metabolic processes.  320 
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     Fatty acids can impact immune responses in several ways apart from simply being an energy source 321 
for the immune cells, including being integral components of cell membrane phospholipids, influencing 322 
the physical and functional properties of membranes, affecting signalling pathways and regulating the 323 
activation of transcription factors and, thus, gene expression [5,30]. It is well-known that different 324 
levels and proportions of the key LC-PUFA, ARA, EPA and DHA, can determine the intensity of the 325 
inflammatory response [7], with a major link between LC-PUFA and inflammation being their role as 326 
precursors of eicosanoids, critical inflammatory mediators. The levels of LC-PUFA in immune cell 327 
membrane phospholipids in fish, as in mammals, are determined by both dietary input and hepatic fatty 328 
acyl desaturase and elongase activities, and delivery via plasma lipoproteins [31,32]. In addition to 329 
liver being a major organ involved in LC-PUFA biosynthesis, liver lesions were reported in fish 330 
affected by HSMI, occurring as a collateral effect of the heart lesions which likely impair blood flow 331 
and hence lipoprotein circulation [3]. Therefore, liver was also investigated in the present study to 332 
determine how the different dietary levels of lipid and EPA (in addition to C18 PUFA precursors) and 333 
disease progression affected the expression of genes of the LC-PUFA biosynthesis pathway. Eight 334 
weeks post-challenge there was higher micro- and macro-vesicular steatosis in fish fed the ST diet 335 
compared with fish fed the functional feeds, which was consistent with the higher levels of TAG and 336 
monounsaturated fatty acids, and lower levels of n-3 PUFA, especially DHA, observed at this time 337 
point in the liver of ST-fed fish. Although the primary cause of the increased steatosis index in ST-fed 338 
fish was not known, the observed differences could simply reflect the differences in dietary fatty acid 339 
composition, leading to higher fatty acid synthesis and deposition. There is however a potential 340 
interaction with the on-going viral infection although previous studies have found no correlation 341 
between the severity of heart and liver lesions during HSMI [4]. However, in the current study, liver 342 
steatosis was usually more frequent when the severity of the heart lesions was high and this was found 343 
in all dietary groups at the end of the trial [18].  344 
    The most notable effect of diet upon the expression of genes of LC-PUFA biosynthesis was the 345 
higher expression of both fatty acyl desaturases in fish fed the functional feeds compared with fish fed 346 
the ST diet. Although this correlates with viral load, it is likely to be due to a general down-regulation 347 
of host cell metabolism rather than a specific effect on desaturase genes per se. Furthermore, the 348 
differences in the feed formulations also offer a possible explanation for the observed effect on 349 
desaturase expression, with the higher lipid (and energy) content of the ST diet being the reason for the 350 
lower expression of desaturases in salmon fed this diet. Previously, it was shown that fatty acyl 351 
desaturase activity was lower in rainbow trout (Oncorhynchus mykiss) consuming high-energy diets 352 
[33]. In addition, the  levels  of  hepatic  mRNA  for  both  Δ6  and  Δ5  desaturases  were 4-fold higher in rats 353 
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fed a fat-free diet in comparison to animals fed diets containing vegetable or fish oils [34]. The precise 354 
mechanism underpinning the increased desaturase expression in animals fed diets of lower energy 355 
(fat/oil) content is unknown. However, the higher expression of Δ6  and  Δ5  fatty acyl desaturases in fish 356 
fed the FF diets would increase their capacity for endogenous production and, possibly, availability of 357 
EPA. The lack of major effects, whether related to nutrition and feed composition or to viral infection, 358 
on the expression of elongases was not unexpected as they do not appear to be under the same level of 359 
transcriptional control as desaturases [35-37]. Further investigation of the relationship between dietary 360 
lipid and energy contents and the expression of genes of the LC-PUFA biosynthesis pathway in 361 
Atlantic salmon without a viral infection is required. However, the present data indicate that, 362 
irrespective of the precise molecular mechanism, LC-PUFA biosynthesis activity in fish fed the ST diet 363 
was low, further limiting the availability of anti-inflammatory n-3 LC-PUFA in these fish in 364 
comparison to fish fed the functional feeds with higher proportions of these fatty acids, highlighting the 365 
crucial role of diet in maintaining the availability of n-3 LC-PUFA in membrane phospholipids. 366 
       PPARs are a group of nuclear transcription factors activated by dietary fatty acids and their 367 
metabolic derivatives that are associated with regulation of lipid metabolism in mammals and fish 368 
[36,38]. Therefore, as differences in lipid and energy contents of the feeds were expected to affect lipid 369 
metabolism pathways, the expression of PPARs was investigated. However, few effects of diet were 370 
observed, with only PPAR in head kidney showing a dietary effect with reduced expression in fish fed 371 
the functional feeds at 16 weeks post infection. In contrast, there were substantial effects related to the 372 
progression of the viral infection or HSMI in the expression of all PPARs, particularly PPAR and 373 
which decreased from 8 to 16 weeks, particularly in head kidney. This is noteworthy as, recently, 374 
there has been interest in the involvement of PPARs in inflammatory processes as they are expressed in 375 
immune cells and activated by eicosanoids [39]. Although all three isoforms of PPAR appear to be 376 
involved in the immune response, most studies in humans focus on the immunomodulatory roles of 377 
PPARα  [40] and  PPARγ  [41]. The expression of PPAR genes decreased during acute inflammation in 378 
lung [40], adipose tissue [42] and activated lymphocytes [43]. In mammals, in vitro studies generally 379 
suggest that PPARs play roles in the resolution of inflammation, regulating the expression of 380 
inflammatory genes such as iNOS2, p38mitogen activated protein (MAP) kinase and STAT1 in the 381 
case  of  PPARγ, and inflammatory mediators such as LTB4 in the case of PPARα  [39]. The results of 382 
the present study on ASRV/HSMI generally agree with those studies suggesting that PPARs may have 383 
similar roles in regulating or modulating inflammatory processes in Atlantic salmon. The considerable 384 
reduction in lipid content observed in head kidney between 8- and 16-weeks post-challenge has not 385 
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been previously reported in fish studies and may be related to the differences in PPAR expression in 386 
head kidney discussed above. However, it is possible that it may also reflect mobilization of immune 387 
cells from this organ towards the tissue sites of infection and inflammation. 388 
       The fatty acid compositions of the major membrane phospholipids in head kidney and heart gave 389 
some insight into the availability of LC-PUFA for the production of inflammatory mediator 390 
eicosanoids [6]. The fatty acid composition of the predominant phospholipid fractions at 8-weeks post-391 
challenge, when no tissue damage in hearts was found irrespective of diet [18] and therefore before the 392 
major inflammatory response to ASRV, showed that the proportions of the main LC-PUFA involved in 393 
inflammatory responses generally reflected the characteristic compositions of PC (higher saturated 394 
fatty acid and EPA) and PE (higher DHA and total PUFA), as reported in previous studies in salmon 395 
[44-45]. The dietary fatty acid composition affected the phospholipid compositions although this varied 396 
between the different LC-PUFA. In this respect, the proportion of ARA in PE of head kidney was not 397 
correlated with levels of dietary ARA, but reflected the levels of precursor 18:2n-6 in the feeds 398 
suggesting in vivo biosynthesis of ARA as previously reported [44].  In contrast, the levels of EPA in 399 
PC, but not in PE, reflected the dietary EPA intakes at 8-weeks. These results are in general agreement 400 
with previous studies in humans and salmon where increased dietary EPA led to increased proportions 401 
of this fatty acid in immune cells and heart [31,44]. However, the levels of LC-PUFA in PC and PE 402 
were significantly impacted during the course of the infection, with ARA and EPA both being 403 
considerably reduced at 16-weeks compared to 8-weeks post-challenge. Importantly, these losses of 404 
ARA and, especially, EPA were somewhat mitigated by the functional feeds, possibly contributing to 405 
the better outcome in fish fed these diets. In contrast, the levels of DHA were relatively unaffected by 406 
diet. It is difficult to predict whether these changes in LC-PUFA composition are cause or effect, or if 407 
they would lead to pro- or anti-inflammatory responses, but it appears clear that EPA and ARA are 408 
released from the membrane to a greater extent than DHA. Further investigation is required to elucidate 409 
if the production of resolvins from DHA are as relevant to the resolution of the inflammatory process in 410 
fish as they are in humans [11].   411 
       The initial step in eicosanoid biosynthesis is the release of LC-PUFA precursors from 412 
phospholipids, mediated by phospholipase A2 (PLA2) that hydrolyzes fatty acids from the sn-2 position 413 
of phospholipids. The above phospholipid fatty acid composition data suggested that there had been 414 
mobilisation of ARA and EPA during the course of the infection. The generally higher expression of 415 
phospholipases, particularly in head kidney, at 8-weeks post-challenge is consistent with the important 416 
role of these enzymes in the initiation of inflammatory processes at early stages of infection. PLA2 is a 417 
family of enzymes with at least 15 isoforms described in mammals with the most accepted 418 
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classification system based on cellular distribution and calcium dependence, including calcium-419 
dependent (cPLA2) and calcium-independent (iPLA2), both cytosolic, and secretory PLA2 (sPLA2) 420 
[46]. To date, most studies in fish have investigated cPLA2 [44,47], but all three classes of PLA2 could 421 
be potentially involved in the inflammatory response. However, research in this field has usually 422 
focussed on the immunomodulatory role of cPLA2 and sPLA2, as iPLA2 is considered more important 423 
for the remodelling of cell membrane phospholipids [8]. 424 
The present study is the first to report the effects of viral infection on the expression of PLA2 genes in 425 
fish. All three main classes of PLA2 were expressed in head kidney, although expression of sPLA2 was 426 
negligible in heart. The higher expression of the three PLA2 at the early (8-week) stage of the disease in 427 
head kidney could indicate an activation of the eicosanoid pathway in macrophages and other immune 428 
related cells present in this tissue, highlighting the importance of the fatty acid composition of the cell 429 
membranes for the synthesis of either pro- or anti-inflammatory eicosanoids. In heart, this pattern of 430 
expression was only observed for cPLA2 in fish fed the FF2 diet. Diet also affected PLA2 expression 431 
with sPLA2 being up-regulated in head kidney of fish fed the functional feeds, and iPLA2 down-432 
regulated in fish fed diet FF2, but the mechanism or significance of these effects are not clear. 433 
Obviously, the present results represent snapshots of gene expression and so can only provide an 434 
indication of the possible inflammatory processes at specific time-points particularly in a largely non-435 
fatal disease such as HSMI that manifests as a long on-going infection. The choice of time points in the 436 
present study was informed by histological data on the progression of inflammatory disease in heart 437 
and liver [18], and may not represent ideal times for assessing all aspects of the inflammatory response.  438 
      In order to broaden scope of the study, the expression of enzymes further downstream in the 439 
production of eicosanoids was assessed. FLAP and ALOX5 are both enzymes involved in the 440 
biosynthesis of leukotrienes, with ARA-derived leukotriene B4 (LTB4) being one of the most critical in 441 
the inflammatory response. LTB4 has an important role during the inflammatory process stimulating 442 
aggregation of neutrophils and promoting leukocyte adherence to the endothelium [48]. Regarding viral 443 
immunity, LTB4 enhances the activity of   NK   cells   and   IFNγ   [31], which are two elements of the 444 
immune system that have been shown to play important roles in the immune response following ASRV 445 
infection [18]. Expression of ALOX5 and FLAP was previously analysed after infection with infectious 446 
salmon anaemia virus (ISAV) and infectious pancreatic necrosis virus (IPNV) and, in both cases, fold 447 
changes were not high even when the inflammatory process was more evident, suggesting that either 448 
the transcriptional regulation of these genes occurs in short periods (pulses) or small changes in 449 
expression are functionally effective [49,50]. In the present study, there was a clear trend for lower 450 
expression, significant at 8-weeks, of ALOX5 and FLAP in head kidney of fish fed the FF1 diet, which 451 
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may indicate lower production of LTB4 that would correlate with the milder inflammatory response in 452 
this dietary group [18].  453 
       In general, viral infections stimulate the production of COX2 in humans and there is evidence that 454 
PGE2, the product of the reaction catalysed by COX2, plays important roles in controlling viral 455 
replication and modulating the inflammatory responses to virus [51]. This prostanoid has also been 456 
related to anti-inflammatory responses, inhibiting the production of LTB4 and other inflammatory 457 
cytokines during resolution of the inflammatory process [11]. However, PGE2 has generally been 458 
regarded as pro-inflammatory and, in the present study, there was a clear trend of higher expression of 459 
COX2 at 16-weeks post-challenge, compared to 8-weeks, in both head kidney and heart in all diets, 460 
particularly fish fed FF1. This was in agreement with previous studies in both humans [51] and fish 461 
[52] where enhanced expression of COX2 along with cytokines involved in the inflammatory response 462 
was reported. Furthermore, the present study also showed a trend of lower expression of COX2 in fish 463 
fed the functional feeds and that could indicate lower production of PGE2 in these fish, consistent with 464 
results from in vitro studies in which increased levels of n-3 PUFA decreased production of PGE2 [31].  465 
        In conclusion, this study on HSMI (ASRV infection) in salmon is the first to evaluate the 466 
expression of a suite of important genes involved in several pathways relating diet, membrane 467 
phospholipid LC-PUFA compositions, and inflammatory responses after a viral infection. Previously, 468 
we showed the potential benefits of using diets with reduced dietary lipid and increased EPA on disease 469 
outcomes [18], and the present study has supported the earlier results with data on the LC-PUFA status 470 
of membrane phospholipids during the course of the infection. In addition, the present study has 471 
demonstrated that liver was also a site for histopathological lesions in HSMI. The observed steatosis in 472 
liver likely reflects a general impairment of lipid metabolism. However, the higher expression of 473 
hepatic Δ6  and  Δ5  desaturases in fish fed the FF diets would increase their capacity for the endogenous 474 
production and availability of anti-inflammatory EPA. Furthermore, mobilization of lipids, changes in 475 
the LC-PUFA composition of membrane PC and PE, along with changes in the expression of genes 476 
related to eicosanoid metabolism pathways, showed the important role played by the head kidney in 477 
inflammatory diseases caused by viral infections. Further studies will be required to elucidate the 478 
crucial role of the production of eicosanoids at different stages of the inflammatory process, especially 479 
at the resolution of inflammation, and how this might be influenced by diet. However, the effects on 480 
gene expression reported in the present study further suggest that, as in humans, clinical nutrition 481 
through functional feeding could be an effective complementary therapy for dealing with emerging 482 
salmon viral diseases associated with long-term inflammation.  483 
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Legends to Figures. 630 
 631 
Fig.1. Liver histology. Micrographs showing different degrees of steatosis. A, Microvesicular steatosis, 632 
0.5 score; B, Moderate steatosis with a mix of microvesicular and some macrovesicular, 2.0 score; 633 
C, Pronounced steatosis dominated by macrovesicular, 3.5 score. The scale bar corresponds to 40 634 
micron. 635 
 636 
Fig. 2. Incidence (percentage of fish sampled) and severity of histopathology (based on the steatosis 637 
scoring system in Table 3) in liver at 8-weeks and 16-weeks post-challenge with Atlantic salmon 638 
reovirus in fish fed the Standard (ST) reference feed and the two functional feeds (FF1 and FF2). 639 
 640 
Fig. 3. Expression of genes of LC-PUFA biosynthesis in liver. Expression of genes involved in long-641 
chain polyunsaturated fatty acid (LC-PUFA) biosynthesis in liver was determined by real-time 642 
quantitative PCR. Values were normalized by dividing the number of copies of the target genes by 643 
the number of copies of reference genes (an average value for the expression of cofilin-2 and elf-644 
1). Different letters represent significant differences between diets within time points and symbols 645 
represents differences between time-points within diets (two-way ANOVA, p<0.05). 646 
 647 
Fig. 4. Expression of PPAR genes in liver. Expression of peroxisome proliferator-activated receptor 648 
(PPAR) genes in liver was determined by real-time quantitative PCR. Values were normalized by 649 
dividing the number of copies of the target genes by the number of copies of reference genes (an 650 
average value for the expression of cofilin-2 and elf-1). Different letters represent significant 651 
differences between diets within time points and symbols represents differences between time-points 652 
within diets (two-way ANOVA, p<0.05). 653 
 654 
Fig. 5. Expression of PPAR genes in head kidney. Expression of peroxisome proliferator-activated 655 
receptor (PPAR) genes in head kidney was determined by real-time quantitative PCR. Values were 656 
normalized by dividing the number of copies of the target genes by the number of copies of 657 
reference genes (an average value for the expression of cofilin-2 and elf-1). Different letters 658 
represent significant differences between diets within time points and symbols represents differences 659 
between time-points within diets (two-way ANOVA, p<0.05). 660 
 661 
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Fig. 6. Expression of genes related to eicosanoid pathways in head kidney. Expression of genes 662 
involved in eicosanoid metabolism pathways was determined in head kidney by real-time 663 
quantitative PCR. Values were normalized by dividing the number of copies of the target genes by 664 
the number of copies of reference genes (an average value for the expression of cofilin-2 and elf-665 
1). Different letters represent significant differences between diets within time points and symbols 666 
represents differences between time-points within diets (two-way ANOVA, p<0.05). 667 
 668 
Fig. 7. Expression of genes related to eicosanoid pathways in heart. Expression of genes involved in 669 
eicosanoid metabolism pathways was determined in heart by real-time quantitative PCR. Values 670 
were normalized by dividing the number of copies of the target genes by the number of copies of 671 
reference genes (an average value for the expression of cofilin-2 and elf-1). Different letters 672 
represent significant differences between diets within time points and symbols represents differences 673 







































































































































































































































Table 1. Formulation and proximate compositions of the feeds 
Component %1 ST FF1 FF2 
Fish meal and hydrolysates 42.1 53 53 
Fish oil 13.7 7 5.2 
Vegetable protein concentrates2 21 18 18 
Vegetable oil 11.2 3 0 
Carbohydrate-based binders3 11.2 12.1 12.1 
Micro premixes4 0.8 1.9 1.7 
Krill meal5 0 5 5 
Krill oil5 0 0 5 
Total 100 100 100 
Proximate composition    
Moisture 6.5 6.5 6.5 
Fat 31 18 18 
Protein 42.2 53.4 53.4 
 
1) All ingredients sourced from EWOS stocks unless otherwise stated. 
2) Includes soy protein concentrate, pea protein concentrate, wheat gluten and sunflower 
meal 
3) Includes wheat grain 
4) Includes vitamins, minerals, crystalline amino acids, ammonium phosphate 




Table 2. Total lipid fatty acid composition (percentage of total fatty acids) and lipid class composition 
(percentage of total lipid) of the experimental diets. ARA, Arachidonic acid; EPA, eicosapentaenoic acid; 
PUFA, polyunsaturated fatty acids. 
Fatty acid ST FF1 FF2 
Saturated 23.97 36.48 31.86 
Monounsaturated 45.73 33.10 37.05 
18:2n-6 10.73 7.11 5.30 
20:3n-6 0.06 0.11 0.10 
20:4n-6 0.36 0.48 0.54 
n-6 PUFA 11.63 8.09 6.50 
18:3n-3 4.62 2.35 1.55 
20:5n-3 4.85 8.76 9.53 
22:6n-3 6.09 5.98 9.03 
n-3 PUFA 17.83 19.83 23.32 
PUFA 30.31 30.42 31.09 
EPA/ARA 13.67 18.16 17.75 
N-3/N-6 1.53 2.45 3.59 
Total PL 8.94 10.77 17.30 
TAG 65.39 53.47 52.45 





Table 3. Scoring of liver steatosis in individual sections was based on the following system.  
0 formation of vacuoles in the cytoplasm, involving less than 10% of the hepatocytes and 
including less than 25% of the area of the individual hepatocytes 
1 formation of vacuoles in the cytoplasm, involving less than 25% of the hepatocytes and 
including less than 25% of the area of the individual hepatocytes 
2 formation of vacuoles in the cytoplasm, involving less than 50% of the hepatocytes and 
including less than 50% of the area of the individual hepatocytes 
3 formation of vacuoles in the cytoplasm, involving less than 75% of the hepatocytes and 
including less than 75% of the area of the individual hepatocytes 
4 formation of vacuoles in the cytoplasm, involving less than 90% of the hepatocytes and 
including less than 80% of the area of the individual hepatocytes 
5 formation of vacuoles in the cytoplasm, involving more than 90% of the hepatocytes and 
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Table 5. Total lipid fatty acid composition (percentage of total fatty acids) of heart from Atlantic salmon fed the 
different diets at 8- and 16- weeks post-infection with PRV.  Results are means ± SD (n = 5).P-values of two-
way ANOVA are presented for factors  ‘diet’,  ‘time’  and  interaction  between  factors 
 ST FF1 FF2 TWO WAY ANOVA P-value 
Liver 8w 16w 8w 16w 8w 16w Diet Week Diet*Week 
Lipid 
content 5.7 ± 0.8 4.3 ± 0.5 4.5 ± 0.4 4.0 ± 0.3 4.3 ± 0.3 3.5 ± 0.2 0.000 0.000 ns 
TPL 37.7 ± 2.4 44.7 ± 2.7 54.0 ± 4.6 50.3 ± 6.4 54.9 ± 3.9 53.5 ± 0.9 0.000 ns 0.007 
TAG 32.4 ± 3.8 14.8 ± 4.0 13.8 ± 6.3 14.9 ± 7.8 12.0 ± 5.1 11.7 ± 2.6 0.000 0.025 0.001 
Head kidney          
Lipid 
content      6.4 ± 0.5 2.9 ± 1.4 8.1 ± 4.4 2.1 ± 0.3 7.1 ± 2.4 1.6 ± 0.4 ns 0.000 ns 
TPL 34.9 ± 4.1 25.2 ± 4.0 32.4 ± 5.2 37.3 ± 5.0 36.5 ± 5.2 38.1 ± 6.8 0.012 ns 0.009 
TAG 42.8 ± 4.2 49.1 ± 8.8 49.6 ± 7.9 35.0 ± 7.0 44.6 ± 7.6 35.8 ± 9.0 ns 0.047 0.016 
Heart          
Lipid 
content 6.5 ± 1.4 5.9 ± 1.8 5.7 ± 1.4 4.0 ± 1.4 7.6 ± 1.4 4.2 ± 2.1 ns 0.003 ns 
TPL 48.7 ± 8.4 30.8 ± 7.1 48.8 ± 7.1 41.5 ± 9.6 45.1 ± 6.6 45.7 ± 7.5 ns 0.008 0.043 





Table 6. Total lipid fatty acid composition (percentage of total fatty acids) of liver from Atlantic salmon fed the 
different diets at 8- and 16- weeks post-infection with PRV.  Results are means ± SD (n = 5).P-values of two-
way  ANOVA  are  presented   for   factors   ‘diet’,   ‘time’  and   interaction  between   factors. ARA, arachidonic acid; 
EPA, eicosapentaenoic acid; ns, not significant (p > 0.05); PUFA, polyunsaturated fatty acids. 
  8 weeks   16 weeks TWO WAY ANOVA P-value 
Fatty acid ST FF1 FF2   ST FF1 FF2 Diet Week Diet*Week 
Saturated 19.1 ± 1.2 26.8 ± 1.4 27.3 ± 1.0  22.5 ± 0.9 25.4 ± 2.0 25.6 ± 0.9 0.000 ns 0.000 
Monounsaturated 42.9 ± 4.2 27.5 ± 5.0 25.7 ± 3.3  31.5 ± 6.2 28.0 ± 3.5 26.6 ± 3.3 0.000 ns 0.008 
18:2n-6 6.5 ± 0.3 3.0 ± 0.2 2.2 ± 0.2  5.5 ± 0.5 3.0 ± 0.5 2.1 ± 0.22 0.000 0.028 0.038 
20:3n-6 0.5 ± 0.1 0.8 ± 0.0 0.6 ± 0.2  0.6 ± 0.1 1.0 ± 0.1 0.8 ± 0.2 0.000 0.009 ns 
20:4n-6 1.8 ± 0.4 2.5 ± 0.5 2.5 ± 0.5  2.3 ± 0.6 2.6 ± 0.4 2.6 ± 0.3 0.020 ns ns 
N-6 PUFA 11.0 ± 0.6 7.4 ± 0.6 6.3 ± 0.7  10.0 ± 0.4 7.7 ± 0.4 6.5 ± 0.5 0.000 ns 0.035 
18:3n-3 2.0 ± 0.1 0.5 ± 0.1 0.3 ± 0.1  1.6 ± 0.2 0.5 ± 0.2 0.3 ± 0.1 0.000 0.031 ns 
20:5n-3 3.8 ± 0.5 7.0 ± 1.1 7.5 ± 1.4  4.9 ± 0.8 7.0 ± 0.6 7.2 ± 0.4 0.000 ns ns 
22:6n-3 18.2 ± 3.6 27.3 ± 4.4 30.0 ± 2.5  26.6 ± 4.5 27.9 ± 2.8 30.2 ± 2.2 0.000 0.018 0.017 
N-3 PUFA 26.7 ± 3.4 37.9 ± 5.4 40.3 ± 2.7  35.6 ± 5.2 38.5 ± 3.1 40.7 ± 2.7 0.000 0.026 0.029 
PUFA 38.0 ± 3.7 45.7 ± 6.0 47.0 ± 3.5  46.0 ± 5.4 46.6 ± 2.8 47.8 ± 3.0 0.022 0.049 ns 
EPA/ARA 2.1 ± 0.4 2.9 ± 0.5 3.1 ± 0.5  2.2 ± 0.3 2.7 ± 0.4 2.8 ± 0.2 0.000 ns ns 




Table 7. Fatty acid compositions (percentage of total fatty acids) of phosphatidylethanolamine and 
phosphatidylcholine of head kidney from Atlantic salmon fed the different diets at 8- and 16- weeks post-
infection with PRV.  Results are means ± SD (n = 5).P-values of two-way ANOVA are presented for factors 
‘diet’,   ‘time’   and   interaction   between   factors.   ARA,   arachidonic   acid; EPA, eicosapentaenoic acid; ns, not 
significant (p > 0.05); PUFA, polyunsaturated fatty acids  
 Phosphatidylethanolamine       
 ST FF1 FF2 TWO WAY ANOVA P-value 
 8w 16w 8w 16w 8w 16w Diet Week Diet*Week 
Saturated 14.5 ± 0.6 14.7 ± 0.6 15.6 ± 0.9 18.2 ± 3.1 16.1 ± 0.6 17.4 ± 1.9 0.007 0.030 ns 
Monounsaturated 17.5 ± 0.6 17.2 ± 1.3 19.9 ± 4.7 18.6 ± 2.9 17.6 ± 2.0 17.5 ± 1.6 ns ns ns  
18:2n-6    4.3 ± 0.1 3.4 ± 0.2 3.6 ± 0.6 2.7 ± 0.3 2.5 ± 0.3 2.0 ± 0.3 0.000 0.000 ns 
20:3n-6    0.3 ± 0.0 0.4 ± 0.1 0.4 ± 0.0 0.4 ± 0.0 0.3 ± 0.0 0.3 ± 0.0 0.000 0.000 0.019 
20:4n-6    3.5 ± 0.3 2.5 ± 0.4 2.8 ± 0.4 2.1 ± 0.2 2.8 ± 0.3 1.6 ± 0.4 0.000 0.000 ns 
Total n-6 PUFA    9.5 ± 0.4 7.6 ± 0.5 7.9 ± 0.3 6.4 ± 0.3 6.5 ± 0.1 4.7 ± 0.7 0.000 0.000 ns 
18:3n-3    0.8 ± 0.2 0.6 ± 0.1 0.6 ± 0.2 0.4 ± 0.1 0.4 ± 0.1 0.3 ± 0.1 0.000 0.000 ns 
20:5n-3  11.3 ± 1.0 5.8 ± 0.8 10.4 ± 1.8 6.2 ± 0.7 12.1 ± 0.8 5.8 ± 0.3 ns 0.000 ns 
22:6n-3  35.8 ± 0.6 38.8 ± 1.5 33.9 ± 4.1 35.8 ± 4.1 36.3 ± 1.6 38.9 ± 2.7 ns 0.030 ns 
Total n-3 PUFA  50.0 ± 1.3 47.1 ± 1.1 47.3 ± 5.6 45.0 ± 5.0 51.0 ± 1.9 47.1 ± 2.7 ns 0.027 ns 
Total PUFA 59.5 ± 1.0 54.7 ± 1.2 55.2 ± 5.4 51.3 ± 5.0 57.5 ± 1.9 51.8 ± 2.4 ns 0.001 ns 
EPA/ARA    3.3 ± 0.6 2.3 ± 0.5 3.7 ± 0.4 3.0 ± 0.5 4.3 ± 0.4 3.8 ± 0.7 0.000 0.001 ns 
n-3/n-6    5.3 ± 0.3 6.2 ± 0.4 6.0 ± 0.9 7.1 ± 0.8 7.8 ± 0.4 10.2 ± 1.7 0.000 0.000 ns 
          
  Phosphatidylcholine       
 ST FF1 FF2 TWO WAY ANOVA P-value 
 8w 16w 8w 16w 8w 16w Diet Week Diet*Week 
Saturated 30.6 ± 2.0 38.1 ± 0.7 35.0 ± 1.2 38.8 ± 1.0 35.1 ± 0.2 38.4 ± 1.2 0.000 0.000 0.001 
Monounsaturated 23.2 ± 2.7 26.2 ± 1.6 19.5 ± 0.5 25.0 ± 1.0 17.7 ± 0.8 23.9 ± 0.5 0.000 0.000 0.023 
18:2n-6 3.1 ± 1.0 2.8 ± 0.0 1.9 ± 0.1 2.1 ± 0.1 1.3 ± 0.1 1.6 ± 0.3 0.000 ns ns 
20:3n-6 0.3 ± 0.1 0.4 ± 0.1 0.4 ± 0.1 0.5 ± 0.1 0.3 ± 0.1 0.4 ± 0.0 0.010 0.017 ns 
20:4n-6 1.7 ± 0.2 1.5 ± 0.1 1.7 ± 0.1 1.5 ± 0.2 1.6 ± 0.1 1.3 ± 0.3 ns 0.002 ns 
Total n-6 PUFA 6.0 ± 1.1 5.6 ± 0.2 4.8 ± 0.3 4.9 ± 0.1 3.8 ± 0.1 3.9 ± 0.5 0.000 ns ns 
18:3n-3 1.0 ± 0.2 0.4 ± 0.3 0.5 ± 0.0 0.3 ± 0.2 0.3 ± 0.0 0.2 ± 0.1 0.000 0.000 ns 
20:5n-3 9.5 ± 0.7 6.5 ± 0.5 11.2 ± 1.1 8.7 ± 1.0 12.7 ± 1.6 9.6 ± 0.5 0.000 0.000 ns 
22:6n-3 24.4 ± 2.9 17.8 ± 1.9 23.6 ± 1.8 16.5 ± 0.9 25.2 ± 1.6 18.2 ± 0.9 ns 0.000 ns 
Total n-3 PUFA 37.0 ± 2.4 26.2 ± 2.0 37.3 ± 2.2 27.3 ± 1.3 40.2 ± 0.8 29.7 ± 1.0 0.000 0.000 ns 
Total PUFA 43.0 ± 1.7 31.8 ± 2.1 42.1 ± 2.1 32.2 ± 1.2 44.1 ± 0.8 33.7 ± 1.1 0.049 0.000 ns 
EPA/ARA 5.6 ± 0.9 4.3 ± 0.7 6.8 ± 1.1 5.9 ± 1.2 8.0 ± 1.3 7.8 ± 1.3 0.000 0.040 ns 





 Table 8. Fatty acid compositions (percentage of total fatty acids) of phosphatidylinositol and 
phosphatidylserine of head kidney from Atlantic salmon fed the different diets at 8- and 16- weeks post-
infection with PRV. Results are means ± SD (n = 5). P-values of two-way ANOVA are presented for factors 
‘diet’,  ‘time’  and  interaction  between  factors.  ARA,  arachidonic  acid; EPA, eicosapentaenoic acid; ns, not 
significant (p > 0.05); PUFA, polyunsaturated fatty acids. 
 
 
Phosphatidylserine       
 
ST FF1 FF2 TWO WAY ANOVA P-value 
 
8w 16w 8w 16w 8w 16w Diet Week Diet x Week 
Saturated 28.9 ± 2.8 29.8 ± 0.7 33.0 ± 0.6 36.1 ± 2.0 31.8 ± 1.9 33.5 ± 0.8 0.000 0.006 ns 
Monounsaturated 11.8 ± 2.4 11.1 ± 1.4 10.4 ± 0.8 13.0 ± 4.1 12.2 ± 4.3 11.7 ± 3.4 ns ns ns 
                18:2n-6 1.4 ± 0.6 1.4 ± 0.2 0.8 ± 0.2 1.1 ± 0.1 1.1 ± 0.6 1.1 ± 0.6 0.018 ns ns 
20:3n-6 0.2 ± 0.0 0.3 ± 0.0 0.2 ± 0.0 0.3 ± 0.0 0.2 ± 0.1 0.2 ± 0.0 ns ns ns 
20:4n-6 1.5 ± 0.4 0.9 ± 0.2 1.4 ± 0.3 0.9 ± 0.2 1.5 ± 0.2 0.8 ± 0.2 ns 0.000 ns 
N-6 PUFA 4.5 ± 0.5 4.3 ± 0.5 3.6 ± 0.4 3.3 ± 0.2 4.0 ± 0.9 3.1 ± 0.5 0.000 0.004 0.062 
18:3n-3 0.5 ± 0.2 0.2 ± 0.1 0.2 ± 0.0 0.2 ± 0.1 0.3 ± 0.2 0.1 ± 0.0 0.018 0.005 ns 
20:5n-3 3.9 ± 1.4 1.8 ± 0.4 3.2 ± 0.6 1.6 ± 0.2 3.4 ± 0.3 1.8 ± 0.1 ns 0.000 ns 
22:6n-3 40.9 ± 3.9 41.4 ± 2.3 39.1 ± 2.1 35.2 ± 3.0 39.0 ± 4.5 38.3 ± 5.8 0.034 ns ns 
N-3 PUFA 47.7 ± 3.2 45.9 ± 2.4 45.5 ± 2.6 40.1 ± 3.5 44.9 ± 4.1 42.8 ± 6.2 0.036 0.084 ns 
Total PUFA 52.2 ± 3.1 50.2 ± 2.2 49.1 ± 2.4 43.4 ± 3.5 48.8 ± 3.3 45.8 ± 5.8 0.005 0.018 ns 
EPA/ARA 3.0 ± 1.1 2.0 ± 0.50 2.3 ± 0.5 1.8 ±0.4 2.3 ± 0.5 2.5  ± 0.5 ns ns ns 





Phosphatidylinositol       
 
ST FF1 FF2 TWO WAY ANOVA P-value 
 
8w 16w 8w 16w 8w 16w Diet Week Diet x Week 
Saturated 26.6 ± 2.2 30.5 ± 0.6 34.1 ± 1.4 35.2 ± 2.1 33.5 ± 2.1 34.4 ± 2.5 0.000 0.013 ns 
Monounsaturated 15.7 ± 5.0 12.5 ± 1.6 12.9 ± 2.1 11.4 ± 2.2 12.4 ± 5.7 12.4 ± 2.8 ns ns ns 
18:2n-6 2.5 ± 2.3 1.9 ± 0.4 1.2 ± 0.3 1.0 ± 0.3 1.3 ± 1.0 0.8 ± 0.2 0.042 ns ns 
20:3n-6 0.6 ± 0.2 0.9 ± 0.1 0.6 ± 0.1 0.6 ± 0.3 0.6 ± 0.1 0.5 ± 0.5 ns ns ns 
20:4n-6 17.3 ± 6.4 23.8 ± 3.2 21.4 ± 1.6 23.1 ± 2.0 20.3 ± 4.2 21.0 ± 2.9 ns 0.048 ns 
N-6 PUFA 21.6 ± 4.6 28.5 ± 2.8 23.8 ± 1.7 25.7 ± 1.7 22.8 ± 3.2 23.2 ± 2.5 ns 0.012 ns 
18:3n-3 0.9 ± 0.6 0.5 ± 0.1 0.3 ± 0.1 0.2 ± 0.0 0.4 ± 0.3 0.2 ± 0.0 0.000 0.008 ns 
20:5n-3 6.8 ± 1.5 3.9 ± 0.9 6.1 ± 1.2 4.7 ± 0.8 8.5 ± 0.9 5.0 ± 1.0 0.022 0.000 ns 
22:6n-3 21.1 ± 1.4 14.7 ± 1.3 14.5 ± 2.0 15.2 ± 2.0 16.1 ± 1.2 16.1 ± 2.6 0.010 0.017 0.002 
N-3 PUFA 30.8 ± 3.4 20.4 ± 1.7 22.4 ± 2.4 21.5 ± 2.3 26.3 ± 1.0 22.5 ± 3.7 0.025 0.000 0.003 
Total PUFA 52.4 ± 2.5 48.9 ± 3.3 46.2 ± 3.0 47.2 ± 3.0 49.2 ± 3.5 45.7 ± 3.8 0.032 ns ns 
EPA/ARA 0.4 ± 0.2  0.3 ±0.4 0.3 ± 0.0 0.2 ± 0.0 0.4 ± 0.0 0.2 ± 0.1 ns 0.000 ns 
n-3/n-6 1.5 ± 0.5 1.0 ± 0.6 0.9 ± 0.1 0.84 ± 0.1 1.2 ± 0.17 1.0 ± 0.22 ns 0.000 0.007 
Table 8.docx
Table 9. Fatty acid compositions (percentage of total fatty acids) of phosphatidylethanolamine and 
phosphatidylcholine of heart from Atlantic salmon fed the different diets at 8- and 16- weeks post-infection with 
PRV.  Results are means ± SD (n = 5). P-values of two-way  ANOVA  are  presented  for  factors  ‘diet’,  ‘time’  and  
interaction between factors. ARA, arachidonic acid; EPA, eicosapentaenoic acid; ns, not significant (p > 0.05); 
PUFA, polyunsaturated fatty acids. 
 Phosphatidylethanolamine       
 ST FF1 FF2 TWO WAY ANOVA P-value 
 8w 16w 8w 16w 8w 16w Diet Week Diet*Week 
Saturated 16.7 ± 0.8 20.3 ± 0.5 16.8 ± 1.0 17.9 ± 0.8 18.6 ± 0.6 17.4 ± 1.1 0.049 0.003 0.000 
Monounsaturated 11.3 ± 0.8 11.6 ± 0.8 10.7 ± 0.5 11.1 ± 2.0 15.0 ± 1.1 11.7 ± 2.2 0.019 ns ns 
18:2n-6 2.5 ± 0.2 2.3 ± 0.3 1.9 ± 0.2 2.4 ± 0.6 1.7 ± 0.3 1.7 ± 0.5 0.016 ns ns 
20:3n-6 0.2 ± 0.0 0.3 ± 0.0 0.3 ± 0.0 0.3 ± 0.0 0.2 ± 0.0 0.3 ± 0.2 ns ns ns 
20:4n-6 1.5 ± 0.0 1.6 ± 0.1 1.4 ± 0.1 1.4 ± 0.1 1.2 ± 0.0 1.4 ± 0.1 0.001 0.028 ns 
Total n-6 PUFA 5.8 ± 0.4 5.5 ± 0.3 5.0 ± 0.3 5.3 ± 0.5 4.1 ± 0.4 4.5 ± 0.7 0.000 ns ns 
18:3n-3 0.7 ± 0.0 0.7 ± 0.1 0.4 ± 0.1 0.7 ± 0.3 0.3 ± 0.1 0.4 ± 0.2 0.002 ns ns 
20:5n-3 4.6 ± 0.5 4.0 ± 0.3 6.0 ± 0.4 5.6 ± 0.6 4.8 ± 0.4 5.5 ± 0.1 0.000 ns 0.010 
22:6n-3 49.1 ± 1.1 47.1 ± 1.9 48.4 ± 0.4 48.2 ± 3.0 45.5 ± 1.8 49.5 ± 2.3 ns ns 0.039 
Total n-3 PUFA 58.4 ± 0.7 54.8 ± 2.0 60.4 ± 0.8 59.1 ± 3.3 54.5 ± 2.5 59.3 ± 2.5 0.032 ns 0.008 
PUFA 64.2 ± 1.0 60.3 ± 2.0 65.4 ± 0.9 64.5 ± 3.0 58.6 ± 2.8 63.8 ± 2.0 0.011 ns 0.003 
EPA/ARA 3.2 ± 0.3 2.6 ± 0.3 4.3 ± 0.5 4.0 ± 0.3 3.9 ± 0.3 4.0 ± 0.3 0.000 0.044 ns 
N-3/N6 10.1 ± 0.6 10.1 ± 0.6 12.1 ± 0.8 11.2 ± 1.6 13.5 ± 0.8 13.5 ± 2.5 0.001 ns ns 
          
          
  Phosphatidylcholine       
 ST FF1 FF2 TWO WAY ANOVA P-value 
 8w 16w 8w 16w 8w 16w Diet Week Diet*Week 
Saturated 33.0 ± 0.8 37.5 ± 2.0 35.1 ± 0.5 37.4 ± 0.7 35.6 ± 2.4 36.4 ± 1.4 ns 0.000 ns 
Monounsaturated 16.2 ± 1.9 17.9 ± 2.2 13.7 ± 0.7 13.4 ± 0.7 14.3 ± 2.6 13.1 ± 1.8 0.001 ns ns 
18:2n-6 1.8 ± 0.3 1.7 ± 0.4 1.2 ± 0.1 1.1 ± 0.1 1.1 ± 0.1 0.8 ± 0.1 0.000 0.048 ns 
20:3n-6 0.2 ± 0.0 0.2 ± 0.1 0.3 ± 0.0 0.3 ± 0.0 0.3 ± 0.0 0.2 ± 0.0 ns ns ns 
20:4n-6 1.9 ± 0.1 1.4 ± 0.1 1.7 ± 0.1 1.6 ± 0.1 1.6 ± 0.1 1.5 ± 0.0 ns 0.000 0.003 
Total n-6 PUFA 4.8 ± 0.4 4.2 ± 0.4 4.0 ± 0.3 3.7 ± 0.2 3.8 ± 0.1 3.3 ± 0.2 0.000 0.001 ns 
18:3n-3 0.7 ± 0.1 0.6 ± 0.1 0.4 ± 0.0 0.3 ± 0.0 0.2 ± 0.0 0.2 ± 0.0 0.000 0.007 ns 
20:5n-3 9.5 ± 1.4 6.0 ± 1.0 12.7 ± 1.2 11.0 ± 0.4 12.8 ± 2.6 11.1 ± 0.4 0.000 0.000 0.067 
22:6n-3 31.2 ± 3.8 29.2 ± 1.4 29.1 ± 1.0 29.8 ± 1.1 29.3 ± 2.9 32.1 ± 2.2 ns ns ns 
Total n-3 PUFA 42.9 ± 2.8 37.1 ± 1.8 44.3 ± 0.9 43.0 ± 0.9 44.2 ± 0.3 45.2 ± 2.5 0.000 0.016 0.007 
PUFA 47.8 ± 2.6 41.4 ± 1.5 48.3 ± 0.8 46.7 ± 0.9 48.0 ± 0.4 48.4 ± 2.4 0.001 0.002 0.003 
EPA/ARA 5.1 ± 0.5 4.2 ± 0.6 7.4 ± 0.6 6.9 ± 0.5 7.9 ± 2.0 7.2 ± 0.4 0.000 0.023 ns 
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Abstract 16 
Heart and Skeletal Muscle Inflammation (HSMI) is an emerging viral disease caused by a novel 17 
Atlantic salmon reovirus (ASRV) affecting farmed fish. Primary symptoms associated with HSMI 18 
include myocardial and skeletal muscle necrosis indicating a severe inflammatory process. Recently, 19 
we applied the concept of clinical nutrition to moderate the long-term inflammatory process associated 20 
with HSMI in salmon subjected to experimental ASRV challenge. The use of functional feeds with 21 
lower lipid (hence energy) content reduced the inflammatory response to ASRV infection and the 22 
severity of associated heart lesions. The aim of the present study was to elucidate possible mechanisms 23 
underpinning the observed effects of the functional feeds, focussing on eicosanoid and fatty acid 24 
metabolism in liver and head kidney. Here we show that liver was also a site for histopathological 25 
lesions in HSMI showing steatosis reflecting impaired lipid metabolism. This study is also the first to 26 
evaluate the expression of a suite of key genes involved in pathways relating diet and membrane 27 
phospholipid fatty acid compositions, and the inflammatory response after ASRV infection. The 28 
expression of hepatic Δ6   and  Δ5  desaturases was higher in fish fed the functional feeds, potentially 29 
increasing their capacity for endogenous production and availability of anti-inflammatory EPA. Effects 30 
on mobilization of lipids and changes in the LC-PUFA composition of membrane phospholipids, along 31 
with significant changes in the expression of the genes related to eicosanoid pathways, showed the 32 
important role of the head kidney in inflammatory diseases caused by viral infections. The results from 33 
the present study suggest that clinical nutrition through functional feeding could be an effective 34 
complementary therapy for emerging salmon viral diseases associated with long-term inflammation. 35 




      Heart and Skeletal Muscle Inflammation (HSMI) is an emerging viral disease caused by a novel 39 
Atlantic salmon reovirus (ASRV) [1] particularly affecting farmed salmon in Norway [2]. Mortality 40 
varies between outbreaks from 0 to 20%, and the morbidity of the lesions can reach 100%, affecting 41 
almost all fish in a farm, leading to significant growth reduction and financial impact [3]. The main 42 
symptoms associated with HSMI are epi-, endo- and myocarditis, and myocardial and red skeletal 43 
muscle necrosis, indicating that these tissues experience a severe inflammatory process. Early stages of 44 
the disease have been reported around five months after transfer to sea water and the cardiac lesions 45 
persist for several months until the fish are able to control the infection and reduce tissue damage [4]. 46 
Thus, factors modulating and dampening the inflammatory process might be key to mitigating the 47 
clinical symptoms and improving performance, including growth, of affected fish. 48 
         Polyunsaturated fatty acids (PUFA), in particular long-chain PUFA (LC-PUFA), have essential 49 
roles in the development and control of inflammatory responses. They are important components of 50 
plasma membranes that are integral in controlling membrane-signalling pathways. A key link between 51 
fatty acid composition of immune cell membranes and the inflammatory process are eicosanoids, lipid 52 
mediators including prostaglandins (PG), leukotrienes (LTB) and thromboxanes (TX) that modulate the 53 
intensity and duration of inflammatory responses in humans [5] and fish [6]. In mammals, arachidonic 54 
acid (ARA, 20:4n-6) is the major LC-PUFA precursor of eicosanoids including leukotriene B4 (LTB4) 55 
and prostaglandin E2 (PGE2), which are two of the main eicosanoids in relation to immune-related 56 
pathways [7,8]. LTB4 is an important chemotactic agent for leukocytes, enhancing the proliferation of 57 
T and B cells, increasing the production of tumour necrosis factor  (TNFα) and interleukins, IL-1 and 58 
IL-6, and inducing NK cell activity, thus being highly relevant in viral infections [9]. PGE2 is generally 59 
related with pro-inflammatory and immunosuppressive functions, although it has also been associated 60 
with anti-inflammatory actions during resolution of the inflammatory process [10]. In contrast, the n-3 61 
LC-PUFA, eicosapentaenoic acid (EPA, 20:5n-3) and docosahexaenoic acid (DHA, 22:6n-3), are 62 
considered anti-inflammatory fatty acids, with EPA being particularly relevant as an antagonist of 63 
ARA, acting as a competitive substrate for the main enzymes of the eicosanoid synthesis pathways, 64 
cyclooxygenase (COX) and lipoxygenase (LOX), giving rise to anti-inflammatory eicosanoids and 65 
inflammation-resolving E-series resolvins [10,11]. Although fish cell membranes have higher levels of 66 
EPA than ARA, previous studies indicated that ARA was the preferred substrate for the enzymes 67 
involved in eicosanoid pathways in fish, as in mammals [12]. Similarly, altering the ratio of ARA and 68 
EPA in cell membranes alters the production of eicosanoids and modulates the inflammatory response 69 
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in fish as it does in mammals [13]. Vegetable oils (VO) are generally rich in n-6 PUFA and do not 70 
contain n-3 LC-PUFA, however, the replacement of dietary fish oil (FO) by VO does not appear to 71 
negatively affect growth performance in salmonids [14]. Therefore VO have been used in the past few 72 
years as a sustainable alternative to dietary FO in fish farming. However, the fatty profiles of the 73 
alternative feeds, especially the reduction in n-3 LC-PUFA levels and the n-3/n-6 PUFA ratio, are 74 
directly reflected in fish tissue fatty acid compositions. This is becoming of increasing interest in 75 
relation to potential modulation of immune and inflammatory response pathways [15-17].  76 
    In this context, we recently applied the concept of clinical nutrition to moderate the long-term 77 
inflammatory process associated with HSMI in salmon [18]. In this study we investigated the effects of 78 
functional feed formulations, in comparison to a standard commercial feed, on inflammatory responses 79 
in the heart of Atlantic salmon subjected to experimental ASRV challenge. The standard reference diet 80 
(ST diet) contained 31% lipid and a digestible energy content of 22 MJ/Kg while the functional feeds 81 
had reduced DE levels (18 MJ/Kg) achieved through lower lipid contents (18%), increased levels of 82 
EPA, and increased n-3/n-6 PUFA and EPA/ARA ratios (FF1 and FF2 diets). A milder (dampened) 83 
inflammatory response to ASRV infection, and reduced severity of heart lesions was found in fish fed 84 
the functional feeds, particularly FF1, and transcriptome (microarray) analysis of heart showed that 85 
expression of inflammation/immune related genes was greatly affected by the functional feeds. This 86 
study demonstrated that dietary modulation through clinical nutrition had major influences on the 87 
development and severity of the response to ASRV infection in salmon, and the modulation of gene 88 
expression between fish fed the different feeds provided insight into the molecular mechanisms of 89 
progression of the inflammatory and immune responses to ASRV infection in salmon. However, the 90 
study did not enable the identification of the precise physiological and molecular mechanisms by which 91 
the functional feeds provided enhanced immuno-inflammatory protection.  92 
        The primary objective of the present study was to elucidate possible mechanisms underpinning the 93 
observed effects of the functional feeds. Given that the main differences between the standard and 94 
functional feeds were in their lipid fractions, this study focussed on lipid metabolism, membrane fatty 95 
acid composition, and fatty acid metabolic pathways involved in LC-PUFA biochemistry and 96 
inflammatory processes, which would be affected by changes in dietary fatty acid composition. Thus, 97 
head kidney, heart and liver from the same fish sampled in the previous study were analysed and fatty 98 
acid compositions of the cell membrane phospholipids were determined. In addition, liver 99 
inflammation was measured, given that it is one of the tissues affected in HSMI, and the expression of 100 
genes, including transcription factors controlling aspects of lipid metabolism, and those involved in 101 
LC-PUFA biosynthesis and eicosanoid metabolism, was determined in liver and head kidney. 102 
 5 
Material and methods 103 
 104 
Fish and feeds 105 
     Three fishmeal-based diets were formulated and manufactured by EWOS Innovation (Dirdal, 106 
Norway).  Formulation and proximate composition of the feeds are indicated in Tables 1 and 2, details 107 
as previously reported [18]. A total of 450 Atlantic salmon (Salmo salar L.), AquaGen strain, were 108 
distributed into nine tanks (50 fish/tank)  at the EWOS facility, Lønningdal, Norway and fed one of the 109 
experimental feeds in triplicate tanks for a period of 8 weeks prior to being transferred to the challenge 110 
facility. All fish were weighed at the start and end of the feeding phase and doubled their weight in the 111 
8-week period. Initial weights (g) were 109 ± 18, 109 ± 19 and 111 ±17, respectively, and final weights 112 
were 199 ± 40, 220 ± 42 and 219 ± 37, respectively, for fish fed the ST, FF1 and FF2 diets (means ± 113 
SD, n = 150). There were no significant differences in initial weights or in final weights between fish 114 
fed any of the treatments.  115 
ASRV Challenge 116 
        After the pre-feeding period, the fish (non-vaccinated) were transferred to the challenge facility at 117 
the Industrial and Aquatic Laboratory (ILAB), Bergen, Norway. A total of 390 fish (130 fish per 118 
treatment), initial average weight 220g (±3.2g, standard error), were distributed into two independent 119 
experimental rooms each containing 9 flow-through tanks (3 tanks per dietary treatment in each 120 
system). Filtered seawater (approximately 30‰) with a constant temperature of 10 ± 1°C was supplied 121 
with a flow sufficient to maintain oxygen concentration in the outlet water at   8 mg/L (48 L / kg fish / 122 
h). The light regime was set at 12h:12h light/dark. The fish were acclimated for 2 weeks prior to 123 
challenge. Fish were fed the same diets during the acclimation period, pre-challenge (8 weeks) and 124 
post-challenge periods (16 weeks) No previous diseases were described. The fish were sedated using 125 
Aqui-S (at final concentration of 5 mg/L of isoeugenol) followed by anaesthesia in benzocaine 126 
(Benzoak) using a final concentration of 30 ml/L of water. After an initial sampling of 10 fish per 127 
dietary treatment, a total of 360 fish (20 per tank; 60 fish per diet per treatment room) were challenged 128 
by intramuscular injection (0.1 ml on each side close to the lateral line) of inoculum collected from cell 129 
culture supernatant of ASRV as described in detail previously [18]. 130 
Sampling 131 
Ten fish from each dietary treatment group (5 fish from each of the two independent systems) were 132 
sampled randomly at 8- and 16-weeks post-challenge. Fish were anaesthetized as above, killed by a 133 
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blow to the head, and heart, liver and head kidney were collected. A part of each liver sample was 134 
transferred to 10% buffered formalin for histological analyses and another part was immediately frozen 135 
in liquid N2 and stored at -80 oC prior to lipid and molecular analyses. Heart and head kidney were also 136 
immediately frozen in liquid N2 and stored at -80 oC. 137 
Liver histology 138 
Liver histology was assessed for micro- and macrovesicular steatosis by light microscopy of 139 
hematoxylin and eosin-stained sections. At least five different fields at 20x original magnification 140 
where examined and scored for presence of formation of vesicles of individual hepatocytes. A 141 
subjective assessment of the proportion of hepatocytes that showed these changes was also made. Liver 142 
steatosis scores were ranked according to a non-continuous score grade from 0 to 5 (Table 3). All 143 
sections were scored double-blinded. A selected proportion of liver samples (n = 15) were stained with 144 
Periodic-Acid Schiff stain (PAS) according to standard methods with the purpose to rule out vacuole 145 
formation as a cause of glycogen storage. Positive samples were included and also treated pre-treated 146 
with diastase/amylase [19]. 147 
      All data preparation and simulation output analysis was conducted using the R language [20]. The 148 
model was a mixed-effects linear model estimated with the lmer function in the lme4 package. The 149 
treatment estimates were based on posterior simulation (n=2500) with 95% credible intervals as 150 
absolute and proportional to the reference level (control diet). Histopathological scores were analysed 151 
by using a multilevel ordered categorical logistic regression because the data are multinomial. The 152 
model was written in BUGS language [21] and fitted with JAGS [22]. Vague non-informative uniform 153 
priors (0,100) were given for the variance parameters and vague non-informative normal priors N (0, 154 
1.0E  +  4)   for   all   other   parameters.   25000   “burn-in" simulation runs were used to adapt the Markov 155 
Chain Monte Carlo (MCMC) before subsequent 2500 runs that were used for inference. Three chains 156 
were run in parallel, i.e. there were a total of 7500 simulations for inference. These were thinned so that 157 
only every 10th simulation was saved to reduce the size of saved objects and to reduce the effects of 158 
autocorrelation. In effect, the posterior density is based on 750 draws from the posterior probability 159 
distribution. Convergence of the MCMC simulation was judged by the Gelman-Rubin convergence 160 
diagnostic. 161 
Lipid analyses 162 
Total lipid from approximately 1g of liver, 0.5 g of head kidney and 0.2g of heart was extracted by 163 
homogenization in chloroform/methanol (2:1, by volume) according to Folch et al. [23], and 164 
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determined gravimetrically. Total lipid from head kidney and heart samples was separated by one-165 
dimensional thin-layer chromatography (TLC) and the major phospholipid classes, phosphatidylcholine 166 
(PC) and phosphatidylethanolamine (PE), were isolated as described previously [24]. Fatty acid methyl 167 
esters (FAME) of heart and head kidney phospholipid classes and liver total lipid were prepared by 168 
acid-catalyzed transmethylation [25]. FAME were separated and quantified by gas chromatography 169 
[26]. Tissue and diet lipid class compositions were determined by single-dimension double-170 
development high-performance thin-layer chromatography (HPTLC) and densitometry [27]. 171 
Significance of differences due to diet and time were determined by two-way ANOVA (p<0.05) using 172 
the SPSS 19.0 statistical package (SPSS Inc., Chicago IL, USA) of arcsin-transformed data. 173 
Real-time quantitative PCR  174 
Expression of 13 selected genes was studied by reverse transcription real time quantitative PCR 175 
(qPCR). Six genes are related to the eicosanoid biosynthesis pathway, secretory phospholipase A2 or 176 
sPLA2 (PLA2G1), cytosolic calcium-dependent phospholipase A2 or cPLA2 (PLA2G4), cytosolic 177 
calcium-independent phospholipase A2 or iPLA2 (PLA2G6), cyclooxygenase 2 (COX2), 5-178 
lipoxygenase-activating protein (FLAP) and arachidonate 5-lipoxygenase (ALOX5). Four genes are 179 
involved in LC-PUFA biosynthesis, Δ5 and Δ6 fatty acyl desaturases (D5FAD, D6FAD) and 180 
elongases 5 and 2 (ELOVL5, ELOVL2). The remaining genes are transcription factors involved in the 181 
regulation of storage and catabolism of dietary fats, and recently associated with the immune response, 182 
peroxisome proliferator-activated receptors α, β and γ (PPAR-A, PPAR-B and PPAR-G). The 183 
primer sequences were obtained either by literature searches or designed from EST sequences 184 
corresponding to candidate genes of interest using the Primer3 software 185 
(http://biotools.umassmed.edu/bioapps/primer3_www.cgi) (Table 4). In addition, amplification of two 186 
reference genes, cofilin-2 and elongation factor-1α  (elf-1α) was performed as they had been identified 187 
in previous salmon qPCR studies as suitable reference genes on the basis of constant expression 188 
between different feeds and time points [18,28], and their expression was equally stable under the 189 
present study’s  conditions.  190 
Details of the qPCR protocol have been reported previously [18]. Briefly, 2 µg of column-purified 191 
total RNA per sample was reverse transcribed into cDNA using the High-Capacity cDNA RT kit 192 
(Applied Biosystems,  Paisley,  U.K.),  following  manufacturer’s  instructions,  using  a  mixture  of  random  193 
primers (1.5µl as supplied) and anchored oligo-dT (0.5 µl at 400 ng/ µl, Eurofins MWG Operon, 194 
Ebersberg, Germany). qPCR amplifications were carried out in duplicate (Quantica, Techne, 195 
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Cambridge, U.K.) in a final volume of 20 µL containing either 5 µL (most genes) or 2 µL (reference 196 
genes and other highly expressed genes) diluted (1/20) cDNA, 0.5 µM of each primer and 10 µL 197 
AbsoluteTM QPCR SYBR® Green mix (ABgene). Results were analysed using the relative expression 198 
software tool (REST 2009, http://www.gene-quantification.info/), which employs a pair-wise fixed 199 
reallocation randomisation test (10,000 randomisations) with efficiency correction to determine the 200 
statistical significance of expression ratios (or gene expression fold-changes) between two treatments 201 
[29]. Additionally, sequencing of amplicons corresponding to new primer designs enabled the 202 




Liver histology  207 
The liver histology scores, based on the degree of steatosis was read as vacuole-formation in 208 
hepatocyte cytoplasm characterised by both micro- and macro-vesicular lesions (Fig.1). There were 209 
clear differences between fish fed the functional feeds and fish fed the ST diet at 8-weeks post-210 
challenge, with the latter group presenting higher micro- and macro-vesicular steatosis. Quantification 211 
of the liver histopathology thus showed that both the incidence (percentage of fish sampled) and 212 
severity (based on the scoring system in Table 3) of steatosis at 8-weeks post challenge was clearly 213 
greater in salmon fed the ST diet compared to fish fed the two functional feeds (Fig. 2). At 16 weeks 214 
post-challenge, there were no longer differences in liver histology between the three dietary treatments. 215 
Lipid content and composition of tissues  216 
The total lipid and triacylglycerol (TAG) contents of liver were lower in fish fed the functional feeds 217 
compared to fish fed the ST diet with higher lipid (Table 5). In contrast, diet had no effect on the total 218 
lipid or TAG contents of heart and head kidney. Total lipid levels in all three tissues decreased during 219 
the time course of the infection irrespective of diet, but a significant interaction between diet and time 220 
was observed for lipid class compositions, given that these showed a change over time that was 221 
variable and dependent on diet.  In liver, this decrease was greatest in fish fed diet ST, which also 222 
showed a large decline in TAG. The decline in tissue lipid content over the course of the infection was 223 
greatest in head kidney. This was associated with decreased percentages of TAG in fish fed the 224 
functional feeds and, conversely, with reduced proportions of polar lipids in fish fed diet ST (Table 5). 225 
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In heart, the results were less clear and the lower lipid content at 16-weeks post-challenge was 226 
associated with lower proportions of polar lipids in fish fed diet ST but lower TAG in fish fed FF2. 227 
Fatty acid compositions of tissues 228 
The fatty acid compositions of the functional feeds were characterised by increased proportions of 229 
saturated and n-3 PUFA, decreased proportions of monoenes and n-6 PUFA, and increased n-3/n-6 230 
PUFA and EPA/ARA ratios (Table 1). The differences in saturated and monounsaturated fatty acid 231 
levels were greatest between diets ST and FF1, whereas the differences in PUFA levels were greatest 232 
between diets ST and FF2. The two functional feeds also varied in the relative proportions of ARA, 233 
EPA and DHA. The fatty acid profile of total lipid of liver generally reflected the composition of the 234 
diets, and therefore showed the same differences between the ST diet and functional feeds, and 235 
between the two functional feeds (Table 6). The overall liver profile changed relatively little during the 236 
course of the infection, especially in the groups of fish eating both functional diets. However, fish fed 237 
the ST diet showed increased proportions of DHA and n-3 PUFA, and decreased proportions of 238 
monoenes at 16 weeks. 239 
      The focus in head kidney and heart was on eicosanoid metabolism, and thus fatty acid compositions 240 
were determined in the main sources of precursor LC-PUFA, the membrane phospholipid classes 241 
phosphatidylcholine (PC),  and phosphatidylethanolamine (PE), phosphatidylinositol (PI) and 242 
phosphatidylserine (PS). The phospholipid fatty acid profiles of the major phospholipids (PC and PE) 243 
in head kidney generally showed in general, some significant effects of diet, including increased 244 
proportions of saturated fatty acids and decreased proportions of n-6 PUFA in fish fed the functional 245 
feeds, but the differences were not as pronounced as in total lipids of liver (Table 7). Irrespective of 246 
diet, the proportions of the major eicosanoid precursors, ARA and EPA and the EPA/ARA ratio, 247 
declined in all head kidney phospholipids, exceptspecially PIE, over the course of the infection, being 248 
significantly reduced in fish at 16-weeks compared to 8-weeks post-challenge (Tables 7 and 8). The 249 
percentage of DHA in PE, PC and PSboth  phospholipid classes was similar in all dietary groups and 250 
decreased in PC, but generally not PE or PS, over the time-course of the infection. In contrast, the 251 
percentage of DHA in PI was higher in fish fed the ST diet at 8 weeks compared to the level in fish fed 252 
the functional feeds, and the level in fish fed all of the diets at 16 weeks post-infection (Table 8). 253 
    As with head kidney, the phospholipid fatty acid composition of the main phospholipid classes of 254 
heart also showed effects of diet over the course of the infection, but they were not very pronounced 255 
and occurred mainly in PC (Table 98). The changes in the proportions of the eicosanoid precursors LC-256 
PUFA showed a different pattern in heart compared to head kidney. Whereas the proportions of ARA 257 
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decreased in PC, they increased in PE, during the course of the infection. However, within an 258 
individual feed, these changes were minimal. In contrast, changes in EPA were more pronounced, 259 
declining in both PC and PE of heart over the course of the infection. Additionally, it was noteworthy 260 
that the decline was much lower in fish fed the functional feeds (Table 98). As a result, although the 261 
EPA/ARA ratio in heart phospholipids decreased over the course of the infection in all treatments, this 262 
was much less pronounced in fish fed the functional feeds. In contrast the n-3/n-6 PUFA ratio did not 263 
change over the course of the infection. Unfortunately, the small amount of tissue available and the low 264 
level of PI and PS precluded the determination of fatty acid compositions of these phospholipid classes 265 
in heart. 266 
 267 
Expression of genes of LC- PUFA biosynthesis pathway in liver 268 
 269 
      The expression of both 6 and 5 fatty acyl desaturases in liver was significantly up-regulated at 270 
both 8- and 16-weeks post-challenge in fish fed the functional feeds compared to fish fed the ST diet 271 
(Fig. 3). There was no difference in expression of these genes between fish fed diets FF1 and FF2, or 272 
between 8- and 16-weeks. In contrast, diet had no significant effects on the expression of fatty acyl 273 
elongases in the liver other than ELOVL5 expression was higher in fish fed diet FF1 compared to fish 274 
fed diet FF2 at 8-weeks post-challenge (Fig. 3). There appeared to be a trend for elongase expression to 275 
be lower at 16-weeks compared to 8-weeks post-challenge, but this was only significant for ELOVL5 276 
in fish fed diet FF1. 277 
Expression of PPARs 278 
     There were no significant effects of diet on the expression of PPARs in liver (Fig. 4). There was a 279 
trend for the expression of all PPAR subtypes to be lower at 16-weeks compared to 8-weeks post-280 
infection in fish fed the ST diet, but this was not statistically significant. Similarly, the expression of 281 
PPAR was lower at 16-weeks compared to 8-weeks post-challenge in all fish, although it was only 282 
significant in fish fed FF1 (Fig. 4). The expression of PPARs in head kidney was also investigated due 283 
to the considerable decrease in lipid content observed in this tissue during the course of the infection, 284 
and the recently reported potential immune modulatory role of these transcription factors (Varga et al. 285 
2011). All three PPAR subtypes showed higher expression at 8-weeks compared to 16-weeks post-286 
challenge, with this being significant in fish fed the functional feeds (Fig. 5). The only significant effect 287 
of  diet  was  increased  expression  of  PPARβ  in  fish  fed  the  ST  diet  compared  to fish fed diet FF2 at16-288 
weeks post-challenge. 289 
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 290 
Expression of genes related to eicosanoid biosynthesis 291 
 292 
 In head kidney, the expression of three phospholipases reported to be involved in the release of 293 
bioactive fatty acids from cell membranes [8] was higher at 8-weeks compared to 16-weeks post-294 
challenge in fish fed all diets, significantly so in fish fed the functional feeds (Fig. 6). At 8-weeks, the 295 
expression of sPLA2 (PLA2G1) was higher in fish fed the functional feeds compared to fish fed the ST 296 
diet, albeit only significant in fish fed diet FF2. The expression of COX2 (prostaglandin synthesis), 297 
ALOX5 and FLAP, both involved in the biosynthesis of LTs, showed generally few differences 298 
between dietary treatments or over the course of the infection.  However, the expression of ALOX5 299 
was lower in fish fed diet FF1 compared to fish fed diet FF2 at 8 weeks, and expression of COX2 was 300 
significantly higher at 16-weeks compared to 8-weeks post-challenge in fish fed diet FF1 (Fig. 6).  301 
      In heart, phospholipases showed a different pattern of expression compared to head kidney (Fig. 7). 302 
Expression of sPLA2 (PLA2G1) was negligible in heart and therefore no qPCR data are shown for this 303 
tissue. There were no major differences in expression of phospholipases over the course of the 304 
infection, other than higher expression of cPLA2 (PLA2G4) at 8- compared to 16-weeks post-challenge 305 
in fish fed diet FF2. Expression of cPLA2 at 16-weeks and iPLA2 (PLA2G6) at 8-weeks was 306 
significantly lower in fish fed diet FF2 compared to fish fed the other diets. Expression of ALOX5 and 307 
FLAP did not differ between the three dietary groups, but there was a trend for FLAP expression to be 308 
higher at 16- compared to 8-weeks post-challenge, although this was only significant in fish fed diet 309 
FF2 (Fig. 7). In general, the expression pattern of COX2 in heart was similar to that observed in head 310 
kidney, with the expression being significantly lower at 8-weeks post-challenge in fish fed the FF1 diet 311 
compared to fish fed the other diets, and with a general up-regulation of this gene in all dietary groups, 312 
significant in diet FF1, at 16- compared to 8-weeks post-challenge (Fig. 7). 313 
Discussion 314 
 315 
As previously described, reduced dietary lipid along with increased dietary EPA and EPA/ARA ratio 316 
can modulate the inflammatory response and consequently reduce the severity of heart lesions caused 317 
by ASRV infection [18]. The present study investigated the metabolic pathways that link fatty acids, 318 
especially LC-PUFA, with the inflammatory response, correlating the previous findings on dietary 319 
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immuno-modulation during ASRV infection, with availability of LC-PUFA and potential effects on 320 
eicosanoid metabolism in the main organs involved in both immune and metabolic processes.  321 
     Fatty acids can impact immune responses in several ways apart from simply being an energy source 322 
for the immune cells, including being integral components of cell membrane phospholipids, influencing 323 
the physical and functional properties of membranes, affecting signalling pathways and regulating the 324 
activation of transcription factors and, thus, gene expression [5,30]. It is well-known that different 325 
levels and proportions of the key LC-PUFA, ARA, EPA and DHA, can determine the intensity of the 326 
inflammatory response [7], with a major link between LC-PUFA and inflammation being their role as 327 
precursors of eicosanoids, critical inflammatory mediators. The levels of LC-PUFA in immune cell 328 
membrane phospholipids in fish, as in mammals, are determined by both dietary input and hepatic fatty 329 
acyl desaturase and elongase activities, and delivery via plasma lipoproteins [31,32]. In addition to 330 
liver being a major organ involved in LC-PUFA biosynthesis, liver lesions were reported in fish 331 
affected by HSMI, occurring as a collateral effect of the heart lesions which likely impair blood flow 332 
and hence lipoprotein circulation [3]. Therefore, liver was also investigated in the present study to 333 
determine how the different dietary levels of lipid and EPA (in addition to C18 PUFA precursors) and 334 
disease progression affected the expression of genes of the LC-PUFA biosynthesis pathway. Eight 335 
weeks post-challenge there was higher micro- and macro-vesicular steatosis in fish fed the ST diet 336 
compared with fish fed the functional feeds, which was consistent with the higher levels of TAG and 337 
monounsaturated fatty acids, and lower levels of n-3 PUFA, especially DHA, observed at this time 338 
point in the liver of ST-fed fish. Although the primary cause of the increased steatosis index in ST-fed 339 
fish was not known, the observed differences could simply reflect the differences in dietary fatty acid 340 
composition, leading to higher fatty acid synthesis and deposition. There is however a potential 341 
interaction with the on-going viral infection although previous studies have found no correlation 342 
between the severity of heart and liver lesions during HSMI [4]. However, in the current study, liver 343 
steatosis was usually more frequent when the severity of the heart lesions was high and this was found 344 
in all dietary groups at the end of the trial [18].  345 
    The most notable effect of diet upon the expression of genes of LC-PUFA biosynthesis was the 346 
higher expression of both fatty acyl desaturases in fish fed the functional feeds compared with fish fed 347 
the ST diet. Although this correlates with viral load, it is likely to be due to a general down-regulation 348 
of host cell metabolism rather than a specific effect on desaturase genes per se. Furthermore, the 349 
differences in the feed formulations also offer a possible explanation for the observed effect on 350 
desaturase expression, with the higher lipid (and energy) content of the ST diet being the reason for the 351 
lower expression of desaturases in salmon fed this diet. Previously, it was shown that fatty acyl 352 
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desaturase activity was lower in rainbow trout (Oncorhynchus mykiss) consuming high-energy diets 353 
[33]. In addition, the  levels  of  hepatic  mRNA  for  both  Δ6  and  Δ5  desaturases  were 4-fold higher in rats 354 
fed a fat-free diet in comparison to animals fed diets containing vegetable or fish oils [34]. The precise 355 
mechanism underpinning the increased desaturase expression in animals fed diets of lower energy 356 
(fat/oil) content is unknown. However, the higher expression of Δ6  and  Δ5  fatty acyl desaturases in fish 357 
fed the FF diets would increase their capacity for endogenous production and, possibly, availability of 358 
EPA. The lack of major effects, whether related to nutrition and feed composition or to viral infection, 359 
on the expression of elongases was not unexpected as they do not appear to be under the same level of 360 
transcriptional control as desaturases [35-37]. Further investigation of the relationship between dietary 361 
lipid and energy contents and the expression of genes of the LC-PUFA biosynthesis pathway in 362 
Atlantic salmon without a viral infection is required. However, the present data indicate that, 363 
irrespective of the precise molecular mechanism, LC-PUFA biosynthesis activity in fish fed the ST diet 364 
was low, further limiting the availability of anti-inflammatory n-3 LC-PUFA in these fish in 365 
comparison to fish fed the functional feeds with higher proportions of these fatty acids, highlighting the 366 
crucial role of diet in maintaining the availability of n-3 LC-PUFA in membrane phospholipids. 367 
       PPARs are a group of nuclear transcription factors activated by dietary fatty acids and their 368 
metabolic derivatives that are associated with regulation of lipid metabolism in mammals and fish 369 
[36,38]. Therefore, as differences in lipid and energy contents of the feeds were expected to affect lipid 370 
metabolism pathways, the expression of PPARs was investigated. However, few effects of diet were 371 
observed, with only PPAR in head kidney showing a dietary effect with reduced expression in fish fed 372 
the functional feeds at 16 weeks post infection. In contrast, there were substantial effects related to the 373 
progression of the viral infection or HSMI in the expression of all PPARs, particularly PPAR and 374 
which decreased from 8 to 16 weeks, particularly in head kidney. This is noteworthy as, recently, 375 
there has been interest in the involvement of PPARs in inflammatory processes as they are expressed in 376 
immune cells and activated by eicosanoids [39]. Although all three isoforms of PPAR appear to be 377 
involved in the immune response, most studies in humans focus on the immunomodulatory roles of 378 
PPARα  [40] and  PPARγ  [41]. The expression of PPAR genes decreased during acute inflammation in 379 
lung [40], adipose tissue [42] and activated lymphocytes [43]. In mammals, in vitro studies generally 380 
suggest that PPARs play roles in the resolution of inflammation, regulating the expression of 381 
inflammatory genes such as iNOS2, p38mitogen activated protein (MAP) kinase and STAT1 in the 382 
case  of  PPARγ, and inflammatory mediators such as LTB4 in the case of PPARα  [39]. The results of 383 
the present study on ASRV/HSMI generally agree with those studies suggesting that PPARs may have 384 
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similar roles in regulating or modulating inflammatory processes in Atlantic salmon. The considerable 385 
reduction in lipid content observed in head kidney between 8- and 16-weeks post-challenge has not 386 
been previously reported in fish studies and may be related to the differences in PPAR expression in 387 
head kidney discussed above. However, it is possible that it may also reflect mobilization of immune 388 
cells from this organ towards the tissue sites of infection and inflammation. 389 
       The fatty acid compositions of the major membrane phospholipids in head kidney and heart gave 390 
some insight into the availability of LC-PUFA for the production of inflammatory mediator 391 
eicosanoids [6]. The fatty acid composition of the predominant phospholipid fractions at 8-weeks post-392 
challenge, when no tissue damage in hearts was found irrespective of diet [18] and therefore before the 393 
major inflammatory response to ASRV, showed that the proportions of the main LC-PUFA involved in 394 
inflammatory responses generally reflected the characteristic compositions of PC (higher saturated 395 
fatty acid and EPA) and PE (higher DHA and total PUFA), as reported in previous studies in salmon 396 
[44-45]. The dietary fatty acid composition affected the phospholipid compositions although this varied 397 
between the different LC-PUFA. In this respect, the proportion of ARA in PE of head kidney was not 398 
correlated with levels of dietary ARA, but reflected the levels of precursor 18:2n-6 in the feeds 399 
suggesting in vivo biosynthesis of ARA as previously reported [44].  In contrast, the levels of EPA in 400 
PC, but not in PE, reflected the dietary EPA intakes at 8-weeks. These results are in general agreement 401 
with previous studies in humans and salmon where increased dietary EPA led to increased proportions 402 
of this fatty acid in immune cells and heart [31,44]. However, the levels of LC-PUFA in PC and PE 403 
were significantly impacted during the course of the infection, with ARA and EPA both being 404 
considerably reduced at 16-weeks compared to 8-weeks post-challenge. Importantly, these losses of 405 
ARA and, especially, EPA were somewhat mitigated by the functional feeds, possibly contributing to 406 
the better outcome in fish fed these diets. In contrast, the levels of DHA were relatively unaffected by 407 
diet. It is difficult to predict whether these changes in LC-PUFA composition are cause or effect, or if 408 
they would lead to pro- or anti-inflammatory responses, but it appears clear that EPA and ARA are 409 
released from the membrane to a greater extent than DHA. Further investigation is required to elucidate 410 
if the production of resolvins from DHA are as relevant to the resolution of the inflammatory process in 411 
fish as they are in humans [11].   412 
       The initial step in eicosanoid biosynthesis is the release of LC-PUFA precursors from 413 
phospholipids, mediated by phospholipase A2 (PLA2) that hydrolyzes fatty acids from the sn-2 position 414 
of phospholipids. The above phospholipid fatty acid composition data suggested that there had been 415 
mobilisation of ARA and EPA during the course of the infection. The generally higher expression of 416 
phospholipases, particularly in head kidney, at 8-weeks post-challenge is consistent with the important 417 
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role of these enzymes in the initiation of inflammatory processes at early stages of infection. PLA2 is a 418 
family of enzymes with at least 15 isoforms described in mammals with the most accepted 419 
classification system based on cellular distribution and calcium dependence, including calcium-420 
dependent (cPLA2) and calcium-independent (iPLA2), both cytosolic, and secretory PLA2 (sPLA2) 421 
[46]. To date, most studies in fish have investigated cPLA2 [44,47], but all three classes of PLA2 could 422 
be potentially involved in the inflammatory response. However, research in this field has usually 423 
focussed on the immunomodulatory role of cPLA2 and sPLA2, as iPLA2 is considered more important 424 
for the remodelling of cell membrane phospholipids [8]. 425 
The present study is the first to report the effects of viral infection on the expression of PLA2 genes in 426 
fish. All three main classes of PLA2 were expressed in head kidney, although expression of sPLA2 was 427 
negligible in heart. The higher expression of the three PLA2 at the early (8-week) stage of the disease in 428 
head kidney could indicate an activation of the eicosanoid pathway in macrophages and other immune 429 
related cells present in this tissue, highlighting the importance of the fatty acid composition of the cell 430 
membranes for the synthesis of either pro- or anti-inflammatory eicosanoids. In heart, this pattern of 431 
expression was only observed for cPLA2 in fish fed the FF2 diet. Diet also affected PLA2 expression 432 
with sPLA2 being up-regulated in head kidney of fish fed the functional feeds, and iPLA2 down-433 
regulated in fish fed diet FF2, but the mechanism or significance of these effects are not clear. 434 
Obviously, the present results represent snapshots of gene expression and so can only provide an 435 
indication of the possible inflammatory processes at specific time-points particularly in a largely non-436 
fatal disease such as HSMI that manifests as a long on-going infection. The choice of time points in the 437 
present study was informed by histological data on the progression of inflammatory disease in heart 438 
and liver [18], and may not represent ideal times for assessing all aspects of the inflammatory response.  439 
      In order to broaden scope of the study, the expression of enzymes further downstream in the 440 
production of eicosanoids was assessed. FLAP and ALOX5 are both enzymes involved in the 441 
biosynthesis of leukotrienes, with ARA-derived leukotriene B4 (LTB4) being one of the most critical in 442 
the inflammatory response. LTB4 has an important role during the inflammatory process stimulating 443 
aggregation of neutrophils and promoting leukocyte adherence to the endothelium [48]. Regarding viral 444 
immunity, LTB4 enhances the activity of   NK   cells   and   IFNγ   [31], which are two elements of the 445 
immune system that have been shown to play important roles in the immune response following ASRV 446 
infection [18]. Expression of ALOX5 and FLAP was previously analysed after infection with infectious 447 
salmon anaemia virus (ISAV) and infectious pancreatic necrosis virus (IPNV) and, in both cases, fold 448 
changes were not high even when the inflammatory process was more evident, suggesting that either 449 
the transcriptional regulation of these genes occurs in short periods (pulses) or small changes in 450 
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expression are functionally effective [49,50]. In the present study, there was a clear trend for lower 451 
expression, significant at 8-weeks, of ALOX5 and FLAP in head kidney of fish fed the FF1 diet, which 452 
may indicate lower production of LTB4 that would correlate with the milder inflammatory response in 453 
this dietary group [18].  454 
       In general, viral infections stimulate the production of COX2 in humans and there is evidence that 455 
PGE2, the product of the reaction catalysed by COX2, plays important roles in controlling viral 456 
replication and modulating the inflammatory responses to virus [51]. This prostanoid has also been 457 
related to anti-inflammatory responses, inhibiting the production of LTB4 and other inflammatory 458 
cytokines during resolution of the inflammatory process [11]. However, PGE2 has generally been 459 
regarded as pro-inflammatory and, in the present study, there was a clear trend of higher expression of 460 
COX2 at 16-weeks post-challenge, compared to 8-weeks, in both head kidney and heart in all diets, 461 
particularly fish fed FF1. This was in agreement with previous studies in both humans [51] and fish 462 
[52] where enhanced expression of COX2 along with cytokines involved in the inflammatory response 463 
was reported. Furthermore, the present study also showed a trend of lower expression of COX2 in fish 464 
fed the functional feeds and that could indicate lower production of PGE2 in these fish, consistent with 465 
results from in vitro studies in which increased levels of n-3 PUFA decreased production of PGE2 [31].  466 
        In conclusion, this study on HSMI (ASRV infection) in salmon is the first to evaluate the 467 
expression of a suite of important genes involved in several pathways relating diet, membrane 468 
phospholipid LC-PUFA compositions, and inflammatory responses after a viral infection. Previously, 469 
we showed the potential benefits of using diets with reduced dietary lipid and increased EPA on disease 470 
outcomes [18], and the present study has supported the earlier results with data on the LC-PUFA status 471 
of membrane phospholipids during the course of the infection. In addition, the present study has 472 
demonstrated that liver was also a site for histopathological lesions in HSMI. The observed steatosis in 473 
liver likely reflects a general impairment of lipid metabolism. However, the higher expression of 474 
hepatic Δ6  and  Δ5  desaturases in fish fed the FF diets would increase their capacity for the endogenous 475 
production and availability of anti-inflammatory EPA. Furthermore, mobilization of lipids, changes in 476 
the LC-PUFA composition of membrane PC and PE, along with changes in the expression of genes 477 
related to eicosanoid metabolism pathways, showed the important role played by the head kidney in 478 
inflammatory diseases caused by viral infections. Further studies will be required to elucidate the 479 
crucial role of the production of eicosanoids at different stages of the inflammatory process, especially 480 
at the resolution of inflammation, and how this might be influenced by diet. However, the effects on 481 
gene expression reported in the present study further suggest that, as in humans, clinical nutrition 482 
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through functional feeding could be an effective complementary therapy for dealing with emerging 483 
salmon viral diseases associated with long-term inflammation.  484 
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